<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://research.alfaar.de/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=WikiSysop</id>
	<title>Alfaar Research - User contributions [en]</title>
	<link rel="self" type="application/atom+xml" href="https://research.alfaar.de/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=WikiSysop"/>
	<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php/Special:Contributions/WikiSysop"/>
	<updated>2026-05-10T16:31:42Z</updated>
	<subtitle>User contributions</subtitle>
	<generator>MediaWiki 1.45.3</generator>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=79</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=79"/>
		<updated>2025-08-30T19:44:27Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
[[Uveal melanoma]] is the most common adult primary ocular malignancy. Here we study its incidence in USA. Here we present the incidence rates between 2001 and 2018 on a nationwide level. &lt;br /&gt;
&lt;br /&gt;
Here we provide interactive graphs to support the readers of our publication to better understand the data.&lt;br /&gt;
[[File:Uveal Melanoma Diagnosis per State.png|thumb|Uveal Melanoma diagnosis per state 2001-2018]]&lt;br /&gt;
&lt;br /&gt;
==== Age-standardized Incidence rates ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?publish=yes Incidence rates per State]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRate-Ratiosperstate/UMRateRatios?publish=yes Incidence rate-ratios per state in comparison to the national incidence in US]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRateperagegroup/IncidenceperAgeGgroupsexFig?pub Incidence rates per age group]&lt;br /&gt;
&lt;br /&gt;
==== Trends: ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforsexraceorigin/UMTrendsSex-Race-Origin?publish=yes Trend for sex, race and origin]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforStageDiag_Confirmation/UMTrendsStage-Diag?publish=yes Trend for stage, and method of diagnostic confirmation]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Uveal Melanoma]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
UMIncidenceRatesperstate/UMIncidenceRates&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=78</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=78"/>
		<updated>2025-08-30T19:31:18Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
[[Uveal melanoma]] is the most common adult primary ocular malignancy. Here we study its incidence in USA. Here we present the incidence rates between 2001 and 2018 on a nationwide level. &lt;br /&gt;
&lt;br /&gt;
Here we provide interactive graphs to support the readers of our publication to better understand the data.&lt;br /&gt;
[[File:Uveal Melanoma Diagnosis per State.png|thumb|Uveal Melanoma diagnosis per state 2001-2018]]&lt;br /&gt;
&lt;br /&gt;
==== Age-standardized Incidence rates ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?publish=yes Incidence rates per State]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRate-Ratiosperstate/UMRateRatios?publish=yes Incidence rate-ratios per state in comparison to the national incidence in US]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRateperagegroup/IncidenceperAgeGgroupsexFig?pub Incidence rates per age group]&lt;br /&gt;
&lt;br /&gt;
==== Trends: ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforsexraceorigin/UMTrendsSex-Race-Origin?publish=yes Trend for sex, race and origin]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforStageDiag_Confirmation/UMTrendsStage-Diag?publish=yes Trend for stage, and method of diagnostic confirmation]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Uveal Melanoma]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;nowiki&amp;gt;&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;br /&gt;
&amp;lt;/nowiki&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=77</id>
		<title>UV and Melanomas in Germany</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=77"/>
		<updated>2023-11-29T13:47:00Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=== DE: UV-Strahlung und Augenmelanome in Deutschland ===&lt;br /&gt;
[[File:UV matters.png|right|frameless|762x762px]]&lt;br /&gt;
&#039;&#039;&#039;Browse&#039;&#039;&#039; [https://public.tableau.com/views/UVandMelanoma/Melanomas?:language=en-US&amp;amp;publish=yes&amp;amp;:display_count=n&amp;amp;:origin=viz_share_link Melanomas Incidence Map in Germany] (interaktive Karte)&lt;br /&gt;
[[File:Asfsee.jpg|left|thumb|By Ahmed Alfaar]]&lt;br /&gt;
&lt;br /&gt;
==== English: ====&lt;br /&gt;
Ultraviolet (UV) radiation and its impact on eye health, specifically in relation to ocular melanoma, is a topic of significant interest and research. Here&#039;s a simplified explanation:&lt;br /&gt;
&lt;br /&gt;
1. &#039;&#039;&#039;UV Radiation and the Eye:&#039;&#039;&#039; UV radiation, a component of sunlight, is known to have various effects on the eye. While it is essential for some bodily functions, excessive exposure can be harmful.&lt;br /&gt;
&lt;br /&gt;
2. &#039;&#039;&#039;Ocular Melanoma:&#039;&#039;&#039;Ocular melanoma is a rare form of cancer that occurs in the eye. It&#039;s not as well-known as skin melanoma but can be equally serious.&lt;br /&gt;
&lt;br /&gt;
3. &#039;&#039;&#039;UV Exposure and Eye Cancer Risk:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Traditionally, it&#039;s been thought that more exposure to UV radiation increases the risk of developing various types of eye conditions, including ocular melanoma.&lt;br /&gt;
&lt;br /&gt;
   - However, recent studies suggest that this relationship might be more complex. The risk may vary depending on the part of the eye affected and other factors like gender and geographical location.&lt;br /&gt;
[[File:Melanomas.png|left|frameless|479x479px]]&lt;br /&gt;
4. &#039;&#039;&#039;Varied Impact Across the Eye:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Different parts of the eye might react differently to UV exposure. For example, certain types of melanoma inside the eye (like in the choroid) might not be as closely linked to UV exposure as previously thought.&lt;br /&gt;
&lt;br /&gt;
   - On the other hand, melanomas in other parts of the eye might still be influenced by UV radiation.&lt;br /&gt;
&lt;br /&gt;
5. &#039;&#039;&#039;Gender and Geographic Differences&#039;&#039;&#039;: The risk of developing ocular melanoma from UV exposure can vary between men and women. Additionally, this risk might not be uniform across different regions, possibly due to varying levels of sunlight intensity.&lt;br /&gt;
&lt;br /&gt;
6. &#039;&#039;&#039;Implications for Prevention&#039;&#039;&#039;:&lt;br /&gt;
&lt;br /&gt;
   - This complexity suggests that a one-size-fits-all approach to preventing ocular melanoma might not be effective. Protective measures might need to be more tailored, considering the specific type of melanoma and individual risk factors.&lt;br /&gt;
&lt;br /&gt;
   - It also highlights the importance of wearing UV-protective eyewear, especially in high-sunlight areas.&lt;br /&gt;
&lt;br /&gt;
7. &#039;&#039;&#039;Need for Further Research&#039;&#039;&#039;: There&#039;s still much to learn about how exactly UV radiation affects the risk of ocular melanoma. Ongoing research is crucial for developing effective prevention and treatment strategies.&lt;br /&gt;
&lt;br /&gt;
In essence, while it&#039;s clear that UV radiation can impact eye health, the specific relationship with ocular melanoma is complex and requires further investigation to fully understand and address.&lt;br /&gt;
&lt;br /&gt;
==== Deutsch: ====&lt;br /&gt;
Ultraviolette (UV) Strahlung und ihre Auswirkungen auf die Augengesundheit, insbesondere in Bezug auf okulare Melanome, sind ein bedeutendes Forschungsthema. Hier ist eine vereinfachte Erklärung:&lt;br /&gt;
&lt;br /&gt;
1. &#039;&#039;&#039;UV-Strahlung und das Auge:&#039;&#039;&#039; UV-Strahlung, ein Bestandteil des Sonnenlichts, ist bekannt für ihre verschiedenen Auswirkungen auf das Auge. Während sie für einige Körperfunktionen essentiell ist, kann eine übermäßige Exposition schädlich sein.&lt;br /&gt;
&lt;br /&gt;
2. &#039;&#039;&#039;Okulares Melanom:&#039;&#039;&#039; Okulares Melanom ist eine seltene Krebsart, die im Auge auftritt. Es ist nicht so bekannt wie Hautmelanom, kann aber ebenso ernst sein.&lt;br /&gt;
&lt;br /&gt;
3. &#039;&#039;&#039;UV-Exposition und Krebsrisiko im Auge:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Traditionell wurde angenommen, dass eine erhöhte Exposition gegenüber UV-Strahlung das Risiko für verschiedene Augenerkrankungen, einschließlich okularer Melanome, steigert.&lt;br /&gt;
&lt;br /&gt;
   - Neuere Studien deuten jedoch darauf hin, dass diese Beziehung komplexer sein könnte. Das Risiko kann je nach betroffenem Teil des Auges und anderen Faktoren wie Geschlecht und geografischer Lage variieren.&lt;br /&gt;
&lt;br /&gt;
4. &#039;&#039;&#039;Unterschiedliche Auswirkungen im Auge:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Verschiedene Teile des Auges könnten unterschiedlich auf UV-Exposition reagieren. Zum Beispiel könnten bestimmte Arten von Melanomen im Auge (wie im Choroid) nicht so eng mit UV-Exposition verbunden sein, wie bisher angenommen.&lt;br /&gt;
&lt;br /&gt;
   - Andererseits könnten Melanome in anderen Teilen des Auges weiterhin durch UV-Strahlung beeinflusst werden.&lt;br /&gt;
&lt;br /&gt;
5. &#039;&#039;&#039;Geschlechts- und geografische Unterschiede:&#039;&#039;&#039; Das Risiko, durch UV-Exposition ein okulares Melanom zu entwickeln, kann zwischen Männern und Frauen variieren. Zusätzlich könnte dieses Risiko in verschiedenen Regionen nicht einheitlich sein, möglicherweise aufgrund unterschiedlicher Sonnenlichtintensitäten.&lt;br /&gt;
&lt;br /&gt;
6. &#039;&#039;&#039;Implikationen für die Prävention&#039;&#039;&#039;:&lt;br /&gt;
&lt;br /&gt;
   - Diese Komplexität deutet darauf hin, dass ein universeller Ansatz zur Prävention von okularem Melanom möglicherweise nicht effektiv ist. Schutzmaßnahmen müssen möglicherweise spezifischer sein, unter Berücksichtigung des spezifischen Melanomtyps und individueller Risikofaktoren.&lt;br /&gt;
&lt;br /&gt;
   - Sie betont auch die Wichtigkeit des Tragens von UV-schützenden Brillen, insbesondere in Gebieten mit starker Sonneneinstrahlung.&lt;br /&gt;
&lt;br /&gt;
7. &#039;&#039;&#039;Bedarf an weiterer Forschung:&#039;&#039;&#039; Es gibt noch viel zu lernen darüber, wie genau UV-Strahlung das Risiko von okularem Melanom beeinflusst. Laufende Forschung ist entscheidend für die Entwicklung effektiver Präventions- und Behandlungsstrategien.&lt;br /&gt;
&lt;br /&gt;
Zusammengefasst ist klar, dass UV-Strahlung die Augengesundheit beeinflussen kann, die spezifische Beziehung zu okularem Melanom jedoch komplex ist und weiter untersucht werden muss, um vollständig verstanden und angegangen zu werden.&lt;br /&gt;
&lt;br /&gt;
[[File:DALL·E 2023-11-28 23.31.56 -.png|center|600x600px]]&lt;br /&gt;
&#039;&#039;&#039;Practical ideas for protecting your eyes from Ultraviolet (UV) light:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
# Wear Sunglasses: Always wear sunglasses that block 99% to 100% of UVA and UVB rays when you are outside during the day. Look for sunglasses that cover your eyes from the side as well.&lt;br /&gt;
# Wear a Hat: A wide-brimmed hat can block about half of UV rays from your eyes and eyelids.&lt;br /&gt;
# Use UV-blocking Contact Lenses: Some contact lenses can block UV rays. While they don’t cover your whole eye and the surrounding areas, they can give you some protection.&lt;br /&gt;
# Wear Prescription Eyeglasses with UV protection: If you wear prescription eyeglasses, you can get lenses with built-in UV protection. Photochromic lenses are a good option.&lt;br /&gt;
# Avoid Sun in Peak Hours: The sun’s rays are strongest between 10 a.m. and 2 p.m., but it’s less about the time and more about the UV index. If the shadows are shorter than you are, seek shade and protect your eyes.&lt;br /&gt;
# Don’t be Fooled by Clouds: The sun’s rays can pass through haze and clouds. So even when it’s cloudy, you should protect your eyes from the sun.&lt;br /&gt;
# Never Look Directly at the Sun: Looking directly at the sun at any time, including during an eclipse, can lead to solar retinopathy, which is damage to the eye’s retina from solar radiation.&lt;br /&gt;
&lt;br /&gt;
Remember, these steps are not just for adults. Children need to protect their eyes from the sun too.&lt;br /&gt;
[[File:MapsRplotuv.jpg|right|frameless|363x363px|UV Germany]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Praktische Ideen, um Ihre Augen vor ultraviolettem (UV) Licht zu schützen:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
# Tragen Sie Sonnenbrillen: Tragen Sie immer Sonnenbrillen, die 99% bis 100% der UVA- und UVB-Strahlen blockieren, wenn Sie tagsüber draußen sind. Suchen Sie nach Sonnenbrillen, die Ihre Augen auch seitlich abdecken.&lt;br /&gt;
# Tragen Sie einen Hut: Ein Hut mit breiter Krempe kann etwa die Hälfte der UV-Strahlen von Ihren Augen und Augenlidern blockieren.&lt;br /&gt;
# Verwenden Sie UV-blockierende Kontaktlinsen: Einige Kontaktlinsen können UV-Strahlen blockieren. Obwohl sie nicht das gesamte Auge und die umliegenden Bereiche abdecken, können sie Ihnen einen gewissen Schutz bieten.&lt;br /&gt;
# Tragen Sie verschreibungspflichtige Brillen mit UV-Schutz: Wenn Sie verschreibungspflichtige Brillen tragen, können Sie Gläser mit eingebautem UV-Schutz erhalten. Photochrome Gläser sind eine gute Option.&lt;br /&gt;
# Vermeiden Sie die Sonne in Spitzenzeiten: Die Strahlen der Sonne sind zwischen 10 und 14 Uhr am stärksten, aber es geht weniger um die Zeit und mehr um den UV-Index. Wenn die Schatten kürzer sind als Sie, suchen Sie Schatten und schützen Sie Ihre Augen.&lt;br /&gt;
# Lassen Sie sich nicht von Wolken täuschen: Die Strahlen der Sonne können durch Dunst und Wolken dringen. Daher sollten Sie Ihre Augen auch bei bewölktem Wetter vor der Sonne schützen.&lt;br /&gt;
# Schauen Sie niemals direkt in die Sonne: Das direkte Betrachten der Sonne zu jeder Zeit, auch während einer Sonnenfinsternis, kann zu einer solaren Retinopathie führen, einer Schädigung der Netzhaut des Auges durch Sonnenstrahlung.&lt;br /&gt;
&lt;br /&gt;
Denken Sie daran, diese Schritte gelten nicht nur für Erwachsene. Auch Kinder müssen ihre Augen vor der Sonne schützen.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Publications:&lt;br /&gt;
&lt;br /&gt;
https://doi.org/10.1007/s00417-021-05317-7&lt;br /&gt;
&lt;br /&gt;
https://doi.org/10.1177/11206721221125018&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=76</id>
		<title>UV and Melanomas in Germany</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=76"/>
		<updated>2023-11-29T01:20:46Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=== DE: UV-Strahlung und Augenmelanome in Deutschland ===&lt;br /&gt;
[[File:UV matters.png|right|frameless|762x762px]]&lt;br /&gt;
&#039;&#039;&#039;Browse&#039;&#039;&#039; [https://public.tableau.com/views/UVandMelanoma/Melanomas?:language=en-US&amp;amp;publish=yes&amp;amp;:display_count=n&amp;amp;:origin=viz_share_link Melanomas Incidence Map in Germany] (interaktive Karte)&lt;br /&gt;
[[File:Asfsee.jpg|left|thumb|By Ahmed Alfaar]]&lt;br /&gt;
&lt;br /&gt;
==== English: ====&lt;br /&gt;
Ultraviolet (UV) radiation and its impact on eye health, specifically in relation to ocular melanoma, is a topic of significant interest and research. Here&#039;s a simplified explanation:&lt;br /&gt;
&lt;br /&gt;
1. &#039;&#039;&#039;UV Radiation and the Eye:&#039;&#039;&#039; UV radiation, a component of sunlight, is known to have various effects on the eye. While it is essential for some bodily functions, excessive exposure can be harmful.&lt;br /&gt;
&lt;br /&gt;
2. &#039;&#039;&#039;Ocular Melanoma:&#039;&#039;&#039;Ocular melanoma is a rare form of cancer that occurs in the eye. It&#039;s not as well-known as skin melanoma but can be equally serious.&lt;br /&gt;
&lt;br /&gt;
3. &#039;&#039;&#039;UV Exposure and Eye Cancer Risk:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Traditionally, it&#039;s been thought that more exposure to UV radiation increases the risk of developing various types of eye conditions, including ocular melanoma.&lt;br /&gt;
&lt;br /&gt;
   - However, recent studies suggest that this relationship might be more complex. The risk may vary depending on the part of the eye affected and other factors like gender and geographical location.&lt;br /&gt;
[[File:Melanomas.png|left|frameless|479x479px]]&lt;br /&gt;
4. &#039;&#039;&#039;Varied Impact Across the Eye:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Different parts of the eye might react differently to UV exposure. For example, certain types of melanoma inside the eye (like in the choroid) might not be as closely linked to UV exposure as previously thought.&lt;br /&gt;
&lt;br /&gt;
   - On the other hand, melanomas in other parts of the eye might still be influenced by UV radiation.&lt;br /&gt;
&lt;br /&gt;
5. &#039;&#039;&#039;Gender and Geographic Differences&#039;&#039;&#039;: The risk of developing ocular melanoma from UV exposure can vary between men and women. Additionally, this risk might not be uniform across different regions, possibly due to varying levels of sunlight intensity.&lt;br /&gt;
&lt;br /&gt;
6. &#039;&#039;&#039;Implications for Prevention&#039;&#039;&#039;:&lt;br /&gt;
&lt;br /&gt;
   - This complexity suggests that a one-size-fits-all approach to preventing ocular melanoma might not be effective. Protective measures might need to be more tailored, considering the specific type of melanoma and individual risk factors.&lt;br /&gt;
&lt;br /&gt;
   - It also highlights the importance of wearing UV-protective eyewear, especially in high-sunlight areas.&lt;br /&gt;
&lt;br /&gt;
7. &#039;&#039;&#039;Need for Further Research&#039;&#039;&#039;: There&#039;s still much to learn about how exactly UV radiation affects the risk of ocular melanoma. Ongoing research is crucial for developing effective prevention and treatment strategies.&lt;br /&gt;
&lt;br /&gt;
In essence, while it&#039;s clear that UV radiation can impact eye health, the specific relationship with ocular melanoma is complex and requires further investigation to fully understand and address.&lt;br /&gt;
&lt;br /&gt;
==== Deutsch: ====&lt;br /&gt;
Ultraviolette (UV) Strahlung und ihre Auswirkungen auf die Augengesundheit, insbesondere in Bezug auf okulare Melanome, sind ein bedeutendes Forschungsthema. Hier ist eine vereinfachte Erklärung:&lt;br /&gt;
&lt;br /&gt;
1. &#039;&#039;&#039;UV-Strahlung und das Auge:&#039;&#039;&#039; UV-Strahlung, ein Bestandteil des Sonnenlichts, ist bekannt für ihre verschiedenen Auswirkungen auf das Auge. Während sie für einige Körperfunktionen essentiell ist, kann eine übermäßige Exposition schädlich sein.&lt;br /&gt;
&lt;br /&gt;
2. &#039;&#039;&#039;Okulares Melanom:&#039;&#039;&#039; Okulares Melanom ist eine seltene Krebsart, die im Auge auftritt. Es ist nicht so bekannt wie Hautmelanom, kann aber ebenso ernst sein.&lt;br /&gt;
&lt;br /&gt;
3. &#039;&#039;&#039;UV-Exposition und Krebsrisiko im Auge:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Traditionell wurde angenommen, dass eine erhöhte Exposition gegenüber UV-Strahlung das Risiko für verschiedene Augenerkrankungen, einschließlich okularer Melanome, steigert.&lt;br /&gt;
&lt;br /&gt;
   - Neuere Studien deuten jedoch darauf hin, dass diese Beziehung komplexer sein könnte. Das Risiko kann je nach betroffenem Teil des Auges und anderen Faktoren wie Geschlecht und geografischer Lage variieren.&lt;br /&gt;
&lt;br /&gt;
4. &#039;&#039;&#039;Unterschiedliche Auswirkungen im Auge:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Verschiedene Teile des Auges könnten unterschiedlich auf UV-Exposition reagieren. Zum Beispiel könnten bestimmte Arten von Melanomen im Auge (wie im Choroid) nicht so eng mit UV-Exposition verbunden sein, wie bisher angenommen.&lt;br /&gt;
&lt;br /&gt;
   - Andererseits könnten Melanome in anderen Teilen des Auges weiterhin durch UV-Strahlung beeinflusst werden.&lt;br /&gt;
&lt;br /&gt;
5. &#039;&#039;&#039;Geschlechts- und geografische Unterschiede:&#039;&#039;&#039; Das Risiko, durch UV-Exposition ein okulares Melanom zu entwickeln, kann zwischen Männern und Frauen variieren. Zusätzlich könnte dieses Risiko in verschiedenen Regionen nicht einheitlich sein, möglicherweise aufgrund unterschiedlicher Sonnenlichtintensitäten.&lt;br /&gt;
&lt;br /&gt;
6. &#039;&#039;&#039;Implikationen für die Prävention&#039;&#039;&#039;:&lt;br /&gt;
&lt;br /&gt;
   - Diese Komplexität deutet darauf hin, dass ein universeller Ansatz zur Prävention von okularem Melanom möglicherweise nicht effektiv ist. Schutzmaßnahmen müssen möglicherweise spezifischer sein, unter Berücksichtigung des spezifischen Melanomtyps und individueller Risikofaktoren.&lt;br /&gt;
&lt;br /&gt;
   - Sie betont auch die Wichtigkeit des Tragens von UV-schützenden Brillen, insbesondere in Gebieten mit starker Sonneneinstrahlung.&lt;br /&gt;
&lt;br /&gt;
7. &#039;&#039;&#039;Bedarf an weiterer Forschung:&#039;&#039;&#039; Es gibt noch viel zu lernen darüber, wie genau UV-Strahlung das Risiko von okularem Melanom beeinflusst. Laufende Forschung ist entscheidend für die Entwicklung effektiver Präventions- und Behandlungsstrategien.&lt;br /&gt;
&lt;br /&gt;
Zusammengefasst ist klar, dass UV-Strahlung die Augengesundheit beeinflussen kann, die spezifische Beziehung zu okularem Melanom jedoch komplex ist und weiter untersucht werden muss, um vollständig verstanden und angegangen zu werden.&lt;br /&gt;
&lt;br /&gt;
[[File:DALL·E 2023-11-28 23.31.56 -.png|center|600x600px]]&lt;br /&gt;
&#039;&#039;&#039;Practical ideas for protecting your eyes from Ultraviolet (UV) light:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
# Wear Sunglasses: Always wear sunglasses that block 99% to 100% of UVA and UVB rays when you are outside during the day. Look for sunglasses that cover your eyes from the side as well.&lt;br /&gt;
# Wear a Hat: A wide-brimmed hat can block about half of UV rays from your eyes and eyelids.&lt;br /&gt;
# Use UV-blocking Contact Lenses: Some contact lenses can block UV rays. While they don’t cover your whole eye and the surrounding areas, they can give you some protection.&lt;br /&gt;
# Wear Prescription Eyeglasses with UV protection: If you wear prescription eyeglasses, you can get lenses with built-in UV protection. Photochromic lenses are a good option.&lt;br /&gt;
# Avoid Sun in Peak Hours: The sun’s rays are strongest between 10 a.m. and 2 p.m., but it’s less about the time and more about the UV index. If the shadows are shorter than you are, seek shade and protect your eyes.&lt;br /&gt;
# Don’t be Fooled by Clouds: The sun’s rays can pass through haze and clouds. So even when it’s cloudy, you should protect your eyes from the sun.&lt;br /&gt;
# Never Look Directly at the Sun: Looking directly at the sun at any time, including during an eclipse, can lead to solar retinopathy, which is damage to the eye’s retina from solar radiation.&lt;br /&gt;
&lt;br /&gt;
Remember, these steps are not just for adults. Children need to protect their eyes from the sun too.&lt;br /&gt;
[[File:MapsRplotuv.jpg|right|frameless|363x363px|UV Germany]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Praktische Ideen, um Ihre Augen vor ultraviolettem (UV) Licht zu schützen:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
# Tragen Sie Sonnenbrillen: Tragen Sie immer Sonnenbrillen, die 99% bis 100% der UVA- und UVB-Strahlen blockieren, wenn Sie tagsüber draußen sind. Suchen Sie nach Sonnenbrillen, die Ihre Augen auch seitlich abdecken.&lt;br /&gt;
# Tragen Sie einen Hut: Ein Hut mit breiter Krempe kann etwa die Hälfte der UV-Strahlen von Ihren Augen und Augenlidern blockieren.&lt;br /&gt;
# Verwenden Sie UV-blockierende Kontaktlinsen: Einige Kontaktlinsen können UV-Strahlen blockieren. Obwohl sie nicht das gesamte Auge und die umliegenden Bereiche abdecken, können sie Ihnen einen gewissen Schutz bieten.&lt;br /&gt;
# Tragen Sie verschreibungspflichtige Brillen mit UV-Schutz: Wenn Sie verschreibungspflichtige Brillen tragen, können Sie Gläser mit eingebautem UV-Schutz erhalten. Photochrome Gläser sind eine gute Option.&lt;br /&gt;
# Vermeiden Sie die Sonne in Spitzenzeiten: Die Strahlen der Sonne sind zwischen 10 und 14 Uhr am stärksten, aber es geht weniger um die Zeit und mehr um den UV-Index. Wenn die Schatten kürzer sind als Sie, suchen Sie Schatten und schützen Sie Ihre Augen.&lt;br /&gt;
# Lassen Sie sich nicht von Wolken täuschen: Die Strahlen der Sonne können durch Dunst und Wolken dringen. Daher sollten Sie Ihre Augen auch bei bewölktem Wetter vor der Sonne schützen.&lt;br /&gt;
# Schauen Sie niemals direkt in die Sonne: Das direkte Betrachten der Sonne zu jeder Zeit, auch während einer Sonnenfinsternis, kann zu einer solaren Retinopathie führen, einer Schädigung der Netzhaut des Auges durch Sonnenstrahlung.&lt;br /&gt;
&lt;br /&gt;
Denken Sie daran, diese Schritte gelten nicht nur für Erwachsene. Auch Kinder müssen ihre Augen vor der Sonne schützen.&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=File:MapsRplotuv.jpg&amp;diff=75</id>
		<title>File:MapsRplotuv.jpg</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=File:MapsRplotuv.jpg&amp;diff=75"/>
		<updated>2023-11-29T01:19:07Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;UV&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=74</id>
		<title>UV and Melanomas in Germany</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=74"/>
		<updated>2023-11-29T01:14:57Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=== DE: UV-Strahlung und Augenmelanome in Deutschland ===&lt;br /&gt;
[[File:UV matters.png|right|frameless|762x762px]]&lt;br /&gt;
&#039;&#039;&#039;Browse&#039;&#039;&#039; [https://public.tableau.com/views/UVandMelanoma/Melanomas?:language=en-US&amp;amp;publish=yes&amp;amp;:display_count=n&amp;amp;:origin=viz_share_link Melanomas Incidence Map in Germany] (interaktive Karte)&lt;br /&gt;
[[File:Asfsee.jpg|left|thumb|By Ahmed Alfaar]]&lt;br /&gt;
&lt;br /&gt;
==== English: ====&lt;br /&gt;
Ultraviolet (UV) radiation and its impact on eye health, specifically in relation to ocular melanoma, is a topic of significant interest and research. Here&#039;s a simplified explanation:&lt;br /&gt;
&lt;br /&gt;
1. &#039;&#039;&#039;UV Radiation and the Eye:&#039;&#039;&#039; UV radiation, a component of sunlight, is known to have various effects on the eye. While it is essential for some bodily functions, excessive exposure can be harmful.&lt;br /&gt;
&lt;br /&gt;
2. &#039;&#039;&#039;Ocular Melanoma:&#039;&#039;&#039;Ocular melanoma is a rare form of cancer that occurs in the eye. It&#039;s not as well-known as skin melanoma but can be equally serious.&lt;br /&gt;
&lt;br /&gt;
3. &#039;&#039;&#039;UV Exposure and Eye Cancer Risk:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Traditionally, it&#039;s been thought that more exposure to UV radiation increases the risk of developing various types of eye conditions, including ocular melanoma.&lt;br /&gt;
&lt;br /&gt;
   - However, recent studies suggest that this relationship might be more complex. The risk may vary depending on the part of the eye affected and other factors like gender and geographical location.&lt;br /&gt;
[[File:Melanomas.png|left|frameless|479x479px]]&lt;br /&gt;
4. &#039;&#039;&#039;Varied Impact Across the Eye:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Different parts of the eye might react differently to UV exposure. For example, certain types of melanoma inside the eye (like in the choroid) might not be as closely linked to UV exposure as previously thought.&lt;br /&gt;
&lt;br /&gt;
   - On the other hand, melanomas in other parts of the eye might still be influenced by UV radiation.&lt;br /&gt;
&lt;br /&gt;
5. &#039;&#039;&#039;Gender and Geographic Differences&#039;&#039;&#039;: The risk of developing ocular melanoma from UV exposure can vary between men and women. Additionally, this risk might not be uniform across different regions, possibly due to varying levels of sunlight intensity.&lt;br /&gt;
&lt;br /&gt;
6. &#039;&#039;&#039;Implications for Prevention&#039;&#039;&#039;:&lt;br /&gt;
&lt;br /&gt;
   - This complexity suggests that a one-size-fits-all approach to preventing ocular melanoma might not be effective. Protective measures might need to be more tailored, considering the specific type of melanoma and individual risk factors.&lt;br /&gt;
&lt;br /&gt;
   - It also highlights the importance of wearing UV-protective eyewear, especially in high-sunlight areas.&lt;br /&gt;
&lt;br /&gt;
7. &#039;&#039;&#039;Need for Further Research&#039;&#039;&#039;: There&#039;s still much to learn about how exactly UV radiation affects the risk of ocular melanoma. Ongoing research is crucial for developing effective prevention and treatment strategies.&lt;br /&gt;
&lt;br /&gt;
In essence, while it&#039;s clear that UV radiation can impact eye health, the specific relationship with ocular melanoma is complex and requires further investigation to fully understand and address.&lt;br /&gt;
&lt;br /&gt;
==== Deutsch: ====&lt;br /&gt;
Ultraviolette (UV) Strahlung und ihre Auswirkungen auf die Augengesundheit, insbesondere in Bezug auf okulare Melanome, sind ein bedeutendes Forschungsthema. Hier ist eine vereinfachte Erklärung:&lt;br /&gt;
&lt;br /&gt;
1. &#039;&#039;&#039;UV-Strahlung und das Auge:&#039;&#039;&#039; UV-Strahlung, ein Bestandteil des Sonnenlichts, ist bekannt für ihre verschiedenen Auswirkungen auf das Auge. Während sie für einige Körperfunktionen essentiell ist, kann eine übermäßige Exposition schädlich sein.&lt;br /&gt;
&lt;br /&gt;
2. &#039;&#039;&#039;Okulares Melanom:&#039;&#039;&#039; Okulares Melanom ist eine seltene Krebsart, die im Auge auftritt. Es ist nicht so bekannt wie Hautmelanom, kann aber ebenso ernst sein.&lt;br /&gt;
&lt;br /&gt;
3. &#039;&#039;&#039;UV-Exposition und Krebsrisiko im Auge:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Traditionell wurde angenommen, dass eine erhöhte Exposition gegenüber UV-Strahlung das Risiko für verschiedene Augenerkrankungen, einschließlich okularer Melanome, steigert.&lt;br /&gt;
&lt;br /&gt;
   - Neuere Studien deuten jedoch darauf hin, dass diese Beziehung komplexer sein könnte. Das Risiko kann je nach betroffenem Teil des Auges und anderen Faktoren wie Geschlecht und geografischer Lage variieren.&lt;br /&gt;
&lt;br /&gt;
4. &#039;&#039;&#039;Unterschiedliche Auswirkungen im Auge:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Verschiedene Teile des Auges könnten unterschiedlich auf UV-Exposition reagieren. Zum Beispiel könnten bestimmte Arten von Melanomen im Auge (wie im Choroid) nicht so eng mit UV-Exposition verbunden sein, wie bisher angenommen.&lt;br /&gt;
&lt;br /&gt;
   - Andererseits könnten Melanome in anderen Teilen des Auges weiterhin durch UV-Strahlung beeinflusst werden.&lt;br /&gt;
&lt;br /&gt;
5. &#039;&#039;&#039;Geschlechts- und geografische Unterschiede:&#039;&#039;&#039; Das Risiko, durch UV-Exposition ein okulares Melanom zu entwickeln, kann zwischen Männern und Frauen variieren. Zusätzlich könnte dieses Risiko in verschiedenen Regionen nicht einheitlich sein, möglicherweise aufgrund unterschiedlicher Sonnenlichtintensitäten.&lt;br /&gt;
&lt;br /&gt;
6. &#039;&#039;&#039;Implikationen für die Prävention&#039;&#039;&#039;:&lt;br /&gt;
&lt;br /&gt;
   - Diese Komplexität deutet darauf hin, dass ein universeller Ansatz zur Prävention von okularem Melanom möglicherweise nicht effektiv ist. Schutzmaßnahmen müssen möglicherweise spezifischer sein, unter Berücksichtigung des spezifischen Melanomtyps und individueller Risikofaktoren.&lt;br /&gt;
&lt;br /&gt;
   - Sie betont auch die Wichtigkeit des Tragens von UV-schützenden Brillen, insbesondere in Gebieten mit starker Sonneneinstrahlung.&lt;br /&gt;
&lt;br /&gt;
7. &#039;&#039;&#039;Bedarf an weiterer Forschung:&#039;&#039;&#039; Es gibt noch viel zu lernen darüber, wie genau UV-Strahlung das Risiko von okularem Melanom beeinflusst. Laufende Forschung ist entscheidend für die Entwicklung effektiver Präventions- und Behandlungsstrategien.&lt;br /&gt;
&lt;br /&gt;
Zusammengefasst ist klar, dass UV-Strahlung die Augengesundheit beeinflussen kann, die spezifische Beziehung zu okularem Melanom jedoch komplex ist und weiter untersucht werden muss, um vollständig verstanden und angegangen zu werden.&lt;br /&gt;
&lt;br /&gt;
[[File:DALL·E 2023-11-28 23.31.56 -.png|center|600x600px]]&lt;br /&gt;
&#039;&#039;&#039;Practical ideas for protecting your eyes from Ultraviolet (UV) light:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
# Wear Sunglasses: Always wear sunglasses that block 99% to 100% of UVA and UVB rays when you are outside during the day. Look for sunglasses that cover your eyes from the side as well.&lt;br /&gt;
# Wear a Hat: A wide-brimmed hat can block about half of UV rays from your eyes and eyelids.&lt;br /&gt;
# Use UV-blocking Contact Lenses: Some contact lenses can block UV rays. While they don’t cover your whole eye and the surrounding areas, they can give you some protection.&lt;br /&gt;
# Wear Prescription Eyeglasses with UV protection: If you wear prescription eyeglasses, you can get lenses with built-in UV protection. Photochromic lenses are a good option.&lt;br /&gt;
# Avoid Sun in Peak Hours: The sun’s rays are strongest between 10 a.m. and 2 p.m., but it’s less about the time and more about the UV index. If the shadows are shorter than you are, seek shade and protect your eyes.&lt;br /&gt;
# Don’t be Fooled by Clouds: The sun’s rays can pass through haze and clouds. So even when it’s cloudy, you should protect your eyes from the sun.&lt;br /&gt;
# Never Look Directly at the Sun: Looking directly at the sun at any time, including during an eclipse, can lead to solar retinopathy, which is damage to the eye’s retina from solar radiation.&lt;br /&gt;
&lt;br /&gt;
Remember, these steps are not just for adults. Children need to protect their eyes from the sun too.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Praktische Ideen, um Ihre Augen vor ultraviolettem (UV) Licht zu schützen:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
# Tragen Sie Sonnenbrillen: Tragen Sie immer Sonnenbrillen, die 99% bis 100% der UVA- und UVB-Strahlen blockieren, wenn Sie tagsüber draußen sind. Suchen Sie nach Sonnenbrillen, die Ihre Augen auch seitlich abdecken.&lt;br /&gt;
# Tragen Sie einen Hut: Ein Hut mit breiter Krempe kann etwa die Hälfte der UV-Strahlen von Ihren Augen und Augenlidern blockieren.&lt;br /&gt;
# Verwenden Sie UV-blockierende Kontaktlinsen: Einige Kontaktlinsen können UV-Strahlen blockieren. Obwohl sie nicht das gesamte Auge und die umliegenden Bereiche abdecken, können sie Ihnen einen gewissen Schutz bieten.&lt;br /&gt;
# Tragen Sie verschreibungspflichtige Brillen mit UV-Schutz: Wenn Sie verschreibungspflichtige Brillen tragen, können Sie Gläser mit eingebautem UV-Schutz erhalten. Photochrome Gläser sind eine gute Option.&lt;br /&gt;
# Vermeiden Sie die Sonne in Spitzenzeiten: Die Strahlen der Sonne sind zwischen 10 und 14 Uhr am stärksten, aber es geht weniger um die Zeit und mehr um den UV-Index. Wenn die Schatten kürzer sind als Sie, suchen Sie Schatten und schützen Sie Ihre Augen.&lt;br /&gt;
# Lassen Sie sich nicht von Wolken täuschen: Die Strahlen der Sonne können durch Dunst und Wolken dringen. Daher sollten Sie Ihre Augen auch bei bewölktem Wetter vor der Sonne schützen.&lt;br /&gt;
# Schauen Sie niemals direkt in die Sonne: Das direkte Betrachten der Sonne zu jeder Zeit, auch während einer Sonnenfinsternis, kann zu einer solaren Retinopathie führen, einer Schädigung der Netzhaut des Auges durch Sonnenstrahlung.&lt;br /&gt;
&lt;br /&gt;
Denken Sie daran, diese Schritte gelten nicht nur für Erwachsene. Auch Kinder müssen ihre Augen vor der Sonne schützen.&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=73</id>
		<title>UV and Melanomas in Germany</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=73"/>
		<updated>2023-11-29T01:06:05Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[File:UV matters.png|right|frameless|762x762px]]&lt;br /&gt;
&#039;&#039;&#039;Browse&#039;&#039;&#039; [https://public.tableau.com/views/UVandMelanoma/Melanomas?:language=en-US&amp;amp;publish=yes&amp;amp;:display_count=n&amp;amp;:origin=viz_share_link Melanomas Incidence Map in Germany]&lt;br /&gt;
[[File:Asfsee.jpg|left|thumb|By Ahmed Alfaar]]&lt;br /&gt;
&lt;br /&gt;
==== English: ====&lt;br /&gt;
Ultraviolet (UV) radiation and its impact on eye health, specifically in relation to ocular melanoma, is a topic of significant interest and research. Here&#039;s a simplified explanation:&lt;br /&gt;
&lt;br /&gt;
1. &#039;&#039;&#039;UV Radiation and the Eye:&#039;&#039;&#039; UV radiation, a component of sunlight, is known to have various effects on the eye. While it is essential for some bodily functions, excessive exposure can be harmful.&lt;br /&gt;
&lt;br /&gt;
2. &#039;&#039;&#039;Ocular Melanoma:&#039;&#039;&#039;Ocular melanoma is a rare form of cancer that occurs in the eye. It&#039;s not as well-known as skin melanoma but can be equally serious.&lt;br /&gt;
&lt;br /&gt;
3. &#039;&#039;&#039;UV Exposure and Eye Cancer Risk:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Traditionally, it&#039;s been thought that more exposure to UV radiation increases the risk of developing various types of eye conditions, including ocular melanoma.&lt;br /&gt;
&lt;br /&gt;
   - However, recent studies suggest that this relationship might be more complex. The risk may vary depending on the part of the eye affected and other factors like gender and geographical location.&lt;br /&gt;
[[File:Melanomas.png|left|frameless|479x479px]]&lt;br /&gt;
4. &#039;&#039;&#039;Varied Impact Across the Eye:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Different parts of the eye might react differently to UV exposure. For example, certain types of melanoma inside the eye (like in the choroid) might not be as closely linked to UV exposure as previously thought.&lt;br /&gt;
&lt;br /&gt;
   - On the other hand, melanomas in other parts of the eye might still be influenced by UV radiation.&lt;br /&gt;
&lt;br /&gt;
5. &#039;&#039;&#039;Gender and Geographic Differences&#039;&#039;&#039;: The risk of developing ocular melanoma from UV exposure can vary between men and women. Additionally, this risk might not be uniform across different regions, possibly due to varying levels of sunlight intensity.&lt;br /&gt;
&lt;br /&gt;
6. &#039;&#039;&#039;Implications for Prevention&#039;&#039;&#039;:&lt;br /&gt;
&lt;br /&gt;
   - This complexity suggests that a one-size-fits-all approach to preventing ocular melanoma might not be effective. Protective measures might need to be more tailored, considering the specific type of melanoma and individual risk factors.&lt;br /&gt;
&lt;br /&gt;
   - It also highlights the importance of wearing UV-protective eyewear, especially in high-sunlight areas.&lt;br /&gt;
&lt;br /&gt;
7. &#039;&#039;&#039;Need for Further Research&#039;&#039;&#039;: There&#039;s still much to learn about how exactly UV radiation affects the risk of ocular melanoma. Ongoing research is crucial for developing effective prevention and treatment strategies.&lt;br /&gt;
&lt;br /&gt;
In essence, while it&#039;s clear that UV radiation can impact eye health, the specific relationship with ocular melanoma is complex and requires further investigation to fully understand and address.&lt;br /&gt;
&lt;br /&gt;
==== Deutsch: ====&lt;br /&gt;
Ultraviolette (UV) Strahlung und ihre Auswirkungen auf die Augengesundheit, insbesondere in Bezug auf okulare Melanome, sind ein bedeutendes Forschungsthema. Hier ist eine vereinfachte Erklärung:&lt;br /&gt;
&lt;br /&gt;
1. &#039;&#039;&#039;UV-Strahlung und das Auge:&#039;&#039;&#039; UV-Strahlung, ein Bestandteil des Sonnenlichts, ist bekannt für ihre verschiedenen Auswirkungen auf das Auge. Während sie für einige Körperfunktionen essentiell ist, kann eine übermäßige Exposition schädlich sein.&lt;br /&gt;
&lt;br /&gt;
2. &#039;&#039;&#039;Okulares Melanom:&#039;&#039;&#039; Okulares Melanom ist eine seltene Krebsart, die im Auge auftritt. Es ist nicht so bekannt wie Hautmelanom, kann aber ebenso ernst sein.&lt;br /&gt;
&lt;br /&gt;
3. &#039;&#039;&#039;UV-Exposition und Krebsrisiko im Auge:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Traditionell wurde angenommen, dass eine erhöhte Exposition gegenüber UV-Strahlung das Risiko für verschiedene Augenerkrankungen, einschließlich okularer Melanome, steigert.&lt;br /&gt;
&lt;br /&gt;
   - Neuere Studien deuten jedoch darauf hin, dass diese Beziehung komplexer sein könnte. Das Risiko kann je nach betroffenem Teil des Auges und anderen Faktoren wie Geschlecht und geografischer Lage variieren.&lt;br /&gt;
&lt;br /&gt;
4. &#039;&#039;&#039;Unterschiedliche Auswirkungen im Auge:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
   - Verschiedene Teile des Auges könnten unterschiedlich auf UV-Exposition reagieren. Zum Beispiel könnten bestimmte Arten von Melanomen im Auge (wie im Choroid) nicht so eng mit UV-Exposition verbunden sein, wie bisher angenommen.&lt;br /&gt;
&lt;br /&gt;
   - Andererseits könnten Melanome in anderen Teilen des Auges weiterhin durch UV-Strahlung beeinflusst werden.&lt;br /&gt;
&lt;br /&gt;
5. &#039;&#039;&#039;Geschlechts- und geografische Unterschiede:&#039;&#039;&#039; Das Risiko, durch UV-Exposition ein okulares Melanom zu entwickeln, kann zwischen Männern und Frauen variieren. Zusätzlich könnte dieses Risiko in verschiedenen Regionen nicht einheitlich sein, möglicherweise aufgrund unterschiedlicher Sonnenlichtintensitäten.&lt;br /&gt;
&lt;br /&gt;
6. &#039;&#039;&#039;Implikationen für die Prävention&#039;&#039;&#039;:&lt;br /&gt;
&lt;br /&gt;
   - Diese Komplexität deutet darauf hin, dass ein universeller Ansatz zur Prävention von okularem Melanom möglicherweise nicht effektiv ist. Schutzmaßnahmen müssen möglicherweise spezifischer sein, unter Berücksichtigung des spezifischen Melanomtyps und individueller Risikofaktoren.&lt;br /&gt;
&lt;br /&gt;
   - Sie betont auch die Wichtigkeit des Tragens von UV-schützenden Brillen, insbesondere in Gebieten mit starker Sonneneinstrahlung.&lt;br /&gt;
&lt;br /&gt;
7. &#039;&#039;&#039;Bedarf an weiterer Forschung:&#039;&#039;&#039; Es gibt noch viel zu lernen darüber, wie genau UV-Strahlung das Risiko von okularem Melanom beeinflusst. Laufende Forschung ist entscheidend für die Entwicklung effektiver Präventions- und Behandlungsstrategien.&lt;br /&gt;
&lt;br /&gt;
Zusammengefasst ist klar, dass UV-Strahlung die Augengesundheit beeinflussen kann, die spezifische Beziehung zu okularem Melanom jedoch komplex ist und weiter untersucht werden muss, um vollständig verstanden und angegangen zu werden.&lt;br /&gt;
&lt;br /&gt;
[[File:DALL·E 2023-11-28 23.31.56 -.png|center|600x600px]]&lt;br /&gt;
&#039;&#039;&#039;Practical ideas for protecting your eyes from Ultraviolet (UV) light:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
# Wear Sunglasses: Always wear sunglasses that block 99% to 100% of UVA and UVB rays when you are outside during the day. Look for sunglasses that cover your eyes from the side as well.&lt;br /&gt;
# Wear a Hat: A wide-brimmed hat can block about half of UV rays from your eyes and eyelids.&lt;br /&gt;
# Use UV-blocking Contact Lenses: Some contact lenses can block UV rays. While they don’t cover your whole eye and the surrounding areas, they can give you some protection.&lt;br /&gt;
# Wear Prescription Eyeglasses with UV protection: If you wear prescription eyeglasses, you can get lenses with built-in UV protection. Photochromic lenses are a good option.&lt;br /&gt;
# Avoid Sun in Peak Hours: The sun’s rays are strongest between 10 a.m. and 2 p.m., but it’s less about the time and more about the UV index. If the shadows are shorter than you are, seek shade and protect your eyes.&lt;br /&gt;
# Don’t be Fooled by Clouds: The sun’s rays can pass through haze and clouds. So even when it’s cloudy, you should protect your eyes from the sun.&lt;br /&gt;
# Never Look Directly at the Sun: Looking directly at the sun at any time, including during an eclipse, can lead to solar retinopathy, which is damage to the eye’s retina from solar radiation.&lt;br /&gt;
&lt;br /&gt;
Remember, these steps are not just for adults. Children need to protect their eyes from the sun too.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Praktische Ideen, um Ihre Augen vor ultraviolettem (UV) Licht zu schützen:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
# Tragen Sie Sonnenbrillen: Tragen Sie immer Sonnenbrillen, die 99% bis 100% der UVA- und UVB-Strahlen blockieren, wenn Sie tagsüber draußen sind. Suchen Sie nach Sonnenbrillen, die Ihre Augen auch seitlich abdecken.&lt;br /&gt;
# Tragen Sie einen Hut: Ein Hut mit breiter Krempe kann etwa die Hälfte der UV-Strahlen von Ihren Augen und Augenlidern blockieren.&lt;br /&gt;
# Verwenden Sie UV-blockierende Kontaktlinsen: Einige Kontaktlinsen können UV-Strahlen blockieren. Obwohl sie nicht das gesamte Auge und die umliegenden Bereiche abdecken, können sie Ihnen einen gewissen Schutz bieten.&lt;br /&gt;
# Tragen Sie verschreibungspflichtige Brillen mit UV-Schutz: Wenn Sie verschreibungspflichtige Brillen tragen, können Sie Gläser mit eingebautem UV-Schutz erhalten. Photochrome Gläser sind eine gute Option.&lt;br /&gt;
# Vermeiden Sie die Sonne in Spitzenzeiten: Die Strahlen der Sonne sind zwischen 10 und 14 Uhr am stärksten, aber es geht weniger um die Zeit und mehr um den UV-Index. Wenn die Schatten kürzer sind als Sie, suchen Sie Schatten und schützen Sie Ihre Augen.&lt;br /&gt;
# Lassen Sie sich nicht von Wolken täuschen: Die Strahlen der Sonne können durch Dunst und Wolken dringen. Daher sollten Sie Ihre Augen auch bei bewölktem Wetter vor der Sonne schützen.&lt;br /&gt;
# Schauen Sie niemals direkt in die Sonne: Das direkte Betrachten der Sonne zu jeder Zeit, auch während einer Sonnenfinsternis, kann zu einer solaren Retinopathie führen, einer Schädigung der Netzhaut des Auges durch Sonnenstrahlung.&lt;br /&gt;
&lt;br /&gt;
Denken Sie daran, diese Schritte gelten nicht nur für Erwachsene. Auch Kinder müssen ihre Augen vor der Sonne schützen.&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=File:Asfsee.jpg&amp;diff=72</id>
		<title>File:Asfsee.jpg</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=File:Asfsee.jpg&amp;diff=72"/>
		<updated>2023-11-29T00:52:08Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Ahmed Alfaar&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=File:SAVE_20230727_163755_adobe_express~4.png&amp;diff=71</id>
		<title>File:SAVE 20230727 163755 adobe express~4.png</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=File:SAVE_20230727_163755_adobe_express~4.png&amp;diff=71"/>
		<updated>2023-11-29T00:38:49Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Ahmed Alfaar&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=File:DALL%C2%B7E_2023-11-28_23.31.56_-.png&amp;diff=70</id>
		<title>File:DALL·E 2023-11-28 23.31.56 -.png</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=File:DALL%C2%B7E_2023-11-28_23.31.56_-.png&amp;diff=70"/>
		<updated>2023-11-29T00:33:26Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Sun at beech&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=File:UV_matters.png&amp;diff=69</id>
		<title>File:UV matters.png</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=File:UV_matters.png&amp;diff=69"/>
		<updated>2023-11-29T00:24:21Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;A dynamic and informative top banner for a website, focusing on UV protection for eye health. The banner depicts a mountain lands&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=File:Melanomas.png&amp;diff=68</id>
		<title>File:Melanomas.png</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=File:Melanomas.png&amp;diff=68"/>
		<updated>2023-11-29T00:23:11Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Melanomas Incidence&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=67</id>
		<title>UV and Melanomas in Germany</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=UV_and_Melanomas_in_Germany&amp;diff=67"/>
		<updated>2023-11-29T00:17:17Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: Created page with &amp;quot;&amp;lt;nowiki&amp;gt;&amp;lt;div class=&amp;#039;tableauPlaceholder&amp;#039; id=&amp;#039;viz1701216972678&amp;#039; style=&amp;#039;position: relative&amp;#039;&amp;gt;&amp;lt;noscript&amp;gt;&amp;lt;a href=&amp;#039;#&amp;#039;&amp;gt;&amp;lt;img alt=&amp;#039;Melanomas &amp;#039; src=&amp;#039;https:&amp;amp;amp;#47;&amp;amp;amp;#47;public.tableau.com&amp;amp;amp;#47;static&amp;amp;amp;#47;images&amp;amp;amp;#47;UV&amp;amp;amp;#47;UVandMelanoma&amp;amp;amp;#47;Melanomas&amp;amp;amp;#47;1_rss.png&amp;#039; style=&amp;#039;border: none&amp;#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;/a&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;/noscript&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;object class=&amp;#039;tableauViz&amp;#039;  style=&amp;#039;display:none;&amp;#039;&amp;gt;&amp;lt;param name=&amp;#039;host_url&amp;#039; value=&amp;#039;https%3A%2F%2Fpublic.tab...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;nowiki&amp;gt;&amp;lt;div class=&#039;tableauPlaceholder&#039; id=&#039;viz1701216972678&#039; style=&#039;position: relative&#039;&amp;gt;&amp;lt;noscript&amp;gt;&amp;lt;a href=&#039;#&#039;&amp;gt;&amp;lt;img alt=&#039;Melanomas &#039; src=&#039;https:&amp;amp;amp;#47;&amp;amp;amp;#47;public.tableau.com&amp;amp;amp;#47;static&amp;amp;amp;#47;images&amp;amp;amp;#47;UV&amp;amp;amp;#47;UVandMelanoma&amp;amp;amp;#47;Melanomas&amp;amp;amp;#47;1_rss.png&#039; style=&#039;border: none&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;/a&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;/noscript&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;object class=&#039;tableauViz&#039;  style=&#039;display:none;&#039;&amp;gt;&amp;lt;param name=&#039;host_url&#039; value=&#039;https%3A%2F%2Fpublic.tableau.com%2F&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt; &amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;embed_code_version&#039; value=&#039;3&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt; &amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;site_root&#039; value=&#039;&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;name&#039; value=&#039;UVandMelanoma&amp;amp;amp;#47;Melanomas&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;tabs&#039; value=&#039;no&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;toolbar&#039; value=&#039;yes&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;static_image&#039; value=&#039;https:&amp;amp;amp;#47;&amp;amp;amp;#47;public.tableau.com&amp;amp;amp;#47;static&amp;amp;amp;#47;images&amp;amp;amp;#47;UV&amp;amp;amp;#47;UVandMelanoma&amp;amp;amp;#47;Melanomas&amp;amp;amp;#47;1.png&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt; &amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;animate_transition&#039; value=&#039;yes&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;display_static_image&#039; value=&#039;yes&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;display_spinner&#039; value=&#039;yes&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;display_overlay&#039; value=&#039;yes&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;display_count&#039; value=&#039;yes&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;language&#039; value=&#039;en-US&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;param name=&#039;filter&#039; value=&#039;publish=yes&#039; /&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;/object&amp;gt;&amp;lt;/nowiki&amp;gt;&amp;lt;nowiki&amp;gt;&amp;lt;/div&amp;gt;&amp;lt;/nowiki&amp;gt;                &amp;lt;nowiki&amp;gt;&amp;lt;script type=&#039;text/javascript&#039;&amp;gt;                    var divElement = document.getElementById(&#039;viz1701216972678&#039;);                    var vizElement = divElement.getElementsByTagName(&#039;object&#039;)[0];                    if ( divElement.offsetWidth &amp;gt; 800 ) { vizElement.style.width=&#039;1000px&#039;;vizElement.style.height=&#039;827px&#039;;} else if ( divElement.offsetWidth &amp;gt; 500 ) { vizElement.style.width=&#039;1000px&#039;;vizElement.style.height=&#039;827px&#039;;} else { vizElement.style.width=&#039;100%&#039;;vizElement.style.height=&#039;777px&#039;;}                     var scriptElement = document.createElement(&#039;script&#039;);                    scriptElement.src = &#039;https://public.tableau.com/javascripts/api/viz_v1.js&#039;&amp;lt;/nowiki&amp;gt;;                    vizElement.parentNode.insertBefore(scriptElement, vizElement);                &amp;lt;nowiki&amp;gt;&amp;lt;/script&amp;gt;&amp;lt;/nowiki&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Main_Page&amp;diff=66</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Main_Page&amp;diff=66"/>
		<updated>2023-02-10T13:19:33Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=== &amp;lt;strong&amp;gt;Recent Publications&amp;lt;/strong&amp;gt; ===&lt;br /&gt;
&#039;&#039;&#039;Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Basel Abdelazeem, Kirellos Said Abbas, Joseph Shehata, Nahla Ahmed El‐Shahat, Mennatullah Mohamed Eltaras, Ibrahim Qaddoumi, Ahmad Samir Alfaar&lt;br /&gt;
&lt;br /&gt;
Cancer Medicine, December 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1002/cam4.5406 DOI: 10.1002/cam4.5406]&lt;br /&gt;
        &lt;br /&gt;
         &lt;br /&gt;
&#039;&#039;&#039;FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Ahmad Samir Alfaar, Lucas Stürzbecher, Maria Diedrichs-Möhring, Marion Lam, Christophe Roubeix, Julia Ritter, Kathrin Schumann, Balasubramaniam Annamalai, Inga-Marie Pompös, Bärbel Rohrer, Florian Sennlaub, Nadine Reichhart, Gerhild Wildner, Olaf Strauß&lt;br /&gt;
&lt;br /&gt;
Journal of Neuroinflammation, October 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1186/s12974-022-02620-w DOI: 10.1186/s12974-022-02620-w]&lt;br /&gt;
&lt;br /&gt;
PMID: [https://www.ncbi.nlm.nih.gov/pubmed/36273134 36273134]         &lt;br /&gt;
        &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;The epidemiology of adults&#039; eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients&#039; data&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Ahmad S Alfaar, C Nathanael Suckert, Matus Rehak, and Christian Girbardt &lt;br /&gt;
&lt;br /&gt;
European Journal of Ophthalmology, October 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1177/11206721221125018 DOI: 10.1177/11206721221125018]&lt;br /&gt;
        &lt;br /&gt;
         &lt;br /&gt;
&#039;&#039;&#039;The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
Ahmad Samir Alfaar, Anas Saad, Peter Wiedemann, Matus Rehak&lt;br /&gt;
&lt;br /&gt;
PMID: [https://pubmed.ncbi.nlm.nih.gov/34605956/ 34605956] DOI: [https://doi.org/10.1007/s00417-021-05317-7 10.1007/s00417-021-05317-7]&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Active Projects&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
* Epidemiology&lt;br /&gt;
** Ocular oncology: in Germany, in USA, in Egypt ( Lid, Orbit, lacrimal gland, Melanoma, Retinoblastoma)&lt;br /&gt;
***[[Uveal Melanoma in USA]]&lt;br /&gt;
** Retinal Diseases&lt;br /&gt;
***Retinopathy of Prematurity: in [[ROP in Germany|Germany]], in USA&lt;br /&gt;
*** Retinal Detachment: in Germany, in USA&lt;br /&gt;
** Ocular Emergencies in Germany&lt;br /&gt;
* Medical Informatics&lt;br /&gt;
* Ocular Physiology&lt;br /&gt;
*Patient-reported outcome measures&lt;br /&gt;
*Clinical Research Interest and Barriers.&lt;br /&gt;
*African Consortium for Genetic and Developmental Eye Diseases&lt;br /&gt;
&lt;br /&gt;
=== My Publications ===&lt;br /&gt;
[[Publications|Complete list of publications]]&lt;br /&gt;
&lt;br /&gt;
 [[mediawikiwiki:Special:MyLanguage/Help:Contents|User&#039;s Guide]] - [[Getting started]]&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Main_Page&amp;diff=65</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Main_Page&amp;diff=65"/>
		<updated>2023-02-10T13:17:30Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=== &amp;lt;strong&amp;gt;Recent Publications&amp;lt;/strong&amp;gt; ===&lt;br /&gt;
&#039;&#039;&#039;Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Basel Abdelazeem, Kirellos Said Abbas, Joseph Shehata, Nahla Ahmed El‐Shahat, Mennatullah Mohamed Eltaras, Ibrahim Qaddoumi, Ahmad Samir Alfaar&lt;br /&gt;
&lt;br /&gt;
Cancer Medicine, December 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1002/cam4.5406 DOI: 10.1002/cam4.5406]&lt;br /&gt;
        &lt;br /&gt;
         &lt;br /&gt;
&#039;&#039;&#039;FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Ahmad Samir Alfaar, Lucas Stürzbecher, Maria Diedrichs-Möhring, Marion Lam, Christophe Roubeix, Julia Ritter, Kathrin Schumann, Balasubramaniam Annamalai, Inga-Marie Pompös, Bärbel Rohrer, Florian Sennlaub, Nadine Reichhart, Gerhild Wildner, Olaf Strauß&lt;br /&gt;
&lt;br /&gt;
Journal of Neuroinflammation, October 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1186/s12974-022-02620-w DOI: 10.1186/s12974-022-02620-w]&lt;br /&gt;
&lt;br /&gt;
[https://www.ncbi.nlm.nih.gov/pubmed/36273134]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;The epidemiology of adults&#039; eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients&#039; data&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Ahmad S Alfaar, C Nathanael Suckert, Matus Rehak, and Christian Girbardt &lt;br /&gt;
&lt;br /&gt;
European Journal of Ophthalmology, October 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1177/11206721221125018 DOI: 10.1177/11206721221125018]&lt;br /&gt;
        &lt;br /&gt;
         &lt;br /&gt;
&#039;&#039;&#039;The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
Ahmad Samir Alfaar, Anas Saad, Peter Wiedemann, Matus Rehak&lt;br /&gt;
&lt;br /&gt;
PMID: [https://pubmed.ncbi.nlm.nih.gov/34605956/ 34605956] DOI: [https://doi.org/10.1007/s00417-021-05317-7 10.1007/s00417-021-05317-7]&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Active Projects&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
* Epidemiology&lt;br /&gt;
** Ocular oncology: in Germany, in USA, in Egypt ( Lid, Orbit, lacrimal gland, Melanoma, Retinoblastoma)&lt;br /&gt;
***[[Uveal Melanoma in USA]]&lt;br /&gt;
** Retinal Diseases&lt;br /&gt;
***Retinopathy of Prematurity: in [[ROP in Germany|Germany]], in USA&lt;br /&gt;
*** Retinal Detachment: in Germany, in USA&lt;br /&gt;
** Ocular Emergencies in Germany&lt;br /&gt;
* Medical Informatics&lt;br /&gt;
* Ocular Physiology&lt;br /&gt;
*Patient-reported outcome measures&lt;br /&gt;
*Clinical Research Interest and Barriers.&lt;br /&gt;
*African Consortium for Genetic and Developmental Eye Diseases&lt;br /&gt;
&lt;br /&gt;
=== My Publications ===&lt;br /&gt;
[[Publications|Complete list of publications]]&lt;br /&gt;
&lt;br /&gt;
 [[mediawikiwiki:Special:MyLanguage/Help:Contents|User&#039;s Guide]] - [[Getting started]]&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Main_Page&amp;diff=64</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Main_Page&amp;diff=64"/>
		<updated>2023-02-10T13:15:43Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=== &amp;lt;strong&amp;gt;Recent Publications&amp;lt;/strong&amp;gt; ===&lt;br /&gt;
&#039;&#039;&#039;Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Basel Abdelazeem, Kirellos Said Abbas, Joseph Shehata, Nahla Ahmed El‐Shahat, Mennatullah Mohamed Eltaras, Ibrahim Qaddoumi, Ahmad Samir Alfaar&lt;br /&gt;
&lt;br /&gt;
Cancer Medicine, December 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1002/cam4.5406 DOI: 10.1002/cam4.5406]&lt;br /&gt;
        &lt;br /&gt;
         &lt;br /&gt;
&#039;&#039;&#039;FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Ahmad Samir Alfaar, Lucas Stürzbecher, Maria Diedrichs-Möhring, Marion Lam, Christophe Roubeix, Julia Ritter, Kathrin Schumann, Balasubramaniam Annamalai, Inga-Marie Pompös, Bärbel Rohrer, Florian Sennlaub, Nadine Reichhart, Gerhild Wildner, Olaf Strauß&lt;br /&gt;
&lt;br /&gt;
Journal of Neuroinflammation, October 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1186/s12974-022-02620-w DOI: 10.1186/s12974-022-02620-w]&lt;br /&gt;
&lt;br /&gt;
[https://www.ncbi.nlm.nih.gov/pubmed/36273134]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;The epidemiology of adults&#039; eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients&#039; data&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Ahmad S Alfaar, C Nathanael Suckert, Matus Rehak, and Christian Girbardt &lt;br /&gt;
&lt;br /&gt;
European Journal of Ophthalmology, October 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1177/11206721221125018 DOI: 10.1177/11206721221125018]&lt;br /&gt;
        &lt;br /&gt;
         &lt;br /&gt;
&#039;&#039;&#039;The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
Ahmad Samir Alfaar, Anas Saad, Peter Wiedemann, Matus Rehak&lt;br /&gt;
&lt;br /&gt;
PMID: [https://pubmed.ncbi.nlm.nih.gov/34605956/ 34605956] DOI: [https://doi.org/10.1007/s00417-021-05317-7 10.1007/s00417-021-05317-7]&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Active Projects&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
* Epidemiology&lt;br /&gt;
** Ocular oncology: in Germany, in USA, in Egypt ( Lid, Orbit, lacrimal gland, Melanoma, Retinoblastoma)&lt;br /&gt;
***[[Uveal Melanoma in USA]]&lt;br /&gt;
** Retinal Diseases&lt;br /&gt;
***Retinopathy of Prematurity: in [[ROP in Germany|Germany]], in USA&lt;br /&gt;
*** Retinal Detachment: in Germany, in USA&lt;br /&gt;
* Medical Informatics&lt;br /&gt;
* Ocular Physiology&lt;br /&gt;
*Patient-reported outcome measures&lt;br /&gt;
*Clinical Research Interest and Barriers.&lt;br /&gt;
*African Consortium for Genetic and Developmental Eye Diseases&lt;br /&gt;
&lt;br /&gt;
=== My Publications ===&lt;br /&gt;
[[Publications|Complete list of publications]]&lt;br /&gt;
&lt;br /&gt;
 [[mediawikiwiki:Special:MyLanguage/Help:Contents|User&#039;s Guide]] - [[Getting started]]&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Main_Page&amp;diff=63</id>
		<title>Main Page</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Main_Page&amp;diff=63"/>
		<updated>2023-02-10T13:13:47Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: /* Active Projects */&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;=== &amp;lt;strong&amp;gt;Recent Publications&amp;lt;/strong&amp;gt; ===&lt;br /&gt;
&#039;&#039;&#039;Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Basel Abdelazeem, Kirellos Said Abbas, Joseph Shehata, Nahla Ahmed El‐Shahat, Mennatullah Mohamed Eltaras, Ibrahim Qaddoumi, Ahmad Samir Alfaar&lt;br /&gt;
&lt;br /&gt;
Cancer Medicine, December 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1002/cam4.5406 DOI: 10.1002/cam4.5406]&lt;br /&gt;
        &lt;br /&gt;
         &lt;br /&gt;
&#039;&#039;&#039;FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Ahmad Samir Alfaar, Lucas Stürzbecher, Maria Diedrichs-Möhring, Marion Lam, Christophe Roubeix, Julia Ritter, Kathrin Schumann, Balasubramaniam Annamalai, Inga-Marie Pompös, Bärbel Rohrer, Florian Sennlaub, Nadine Reichhart, Gerhild Wildner, Olaf Strauß&lt;br /&gt;
&lt;br /&gt;
Journal of Neuroinflammation, October 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1186/s12974-022-02620-w DOI: 10.1186/s12974-022-02620-w]&lt;br /&gt;
&lt;br /&gt;
[https://www.ncbi.nlm.nih.gov/pubmed/36273134 https://www.ncbi] PMID: &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;The epidemiology of adults&#039; eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients&#039; data&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Ahmad S Alfaar, C Nathanael Suckert, Matus Rehak, and Christian Girbardt &lt;br /&gt;
&lt;br /&gt;
European Journal of Ophthalmology, October 2022&lt;br /&gt;
&lt;br /&gt;
[https://doi.org/10.1177/11206721221125018 DOI: 10.1177/11206721221125018]&lt;br /&gt;
        &lt;br /&gt;
         &lt;br /&gt;
&#039;&#039;&#039;The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015&#039;&#039;&#039; &lt;br /&gt;
&lt;br /&gt;
Ahmad Samir Alfaar, Anas Saad, Peter Wiedemann, Matus Rehak&lt;br /&gt;
&lt;br /&gt;
PMID: [https://pubmed.ncbi.nlm.nih.gov/34605956/ 34605956] DOI: [https://doi.org/10.1007/s00417-021-05317-7 10.1007/s00417-021-05317-7]&lt;br /&gt;
&lt;br /&gt;
=== &#039;&#039;&#039;Active Projects&#039;&#039;&#039; ===&lt;br /&gt;
&lt;br /&gt;
* Epidemiology&lt;br /&gt;
** Ocular oncology: in Germany, in USA, in Egypt ( Lid, Orbit, lacrimal gland, Melanoma, Retinoblastoma)&lt;br /&gt;
***[[Uveal Melanoma in USA]]&lt;br /&gt;
** Retinal Diseases&lt;br /&gt;
***Retinopathy of Prematurity: in [[ROP in Germany|Germany]], in USA&lt;br /&gt;
*** Retinal Detachment: in Germany, in USA&lt;br /&gt;
* Medical Informatics&lt;br /&gt;
* Ocular Physiology&lt;br /&gt;
*Patient-reported outcome measures&lt;br /&gt;
*Clinical Research Interest and Barriers.&lt;br /&gt;
*African Consortium for Genetic and Developmental Eye Diseases&lt;br /&gt;
&lt;br /&gt;
=== My Publications ===&lt;br /&gt;
[[Publications|Complete list of publications]]&lt;br /&gt;
&lt;br /&gt;
 [[mediawikiwiki:Special:MyLanguage/Help:Contents|User&#039;s Guide]] - [[Getting started]]&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=62</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=62"/>
		<updated>2023-02-10T10:38:10Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Authors&lt;br /&gt;
!Title&lt;br /&gt;
!Journal&lt;br /&gt;
!Online&lt;br /&gt;
!Volume, Issue, Pages&lt;br /&gt;
!DOI&lt;br /&gt;
!IF&lt;br /&gt;
!Rank&lt;br /&gt;
!Theme&lt;br /&gt;
!Submitted&lt;br /&gt;
!Accepted&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A.&lt;br /&gt;
|International telepharmacy education: another venue to improve cancer care in the developing world.&lt;br /&gt;
|&#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;18&#039;&#039;(6), 470–474.&lt;br /&gt;
|https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
|5.033&lt;br /&gt;
|Q1&lt;br /&gt;
|Education&lt;br /&gt;
|August 31, 2011&lt;br /&gt;
|November 29, 2011&lt;br /&gt;
|-&lt;br /&gt;
|Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., &#039;&#039;&#039;Samir&#039;&#039;&#039;, A., &amp;amp; Younes, A. A. &lt;br /&gt;
|Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &lt;br /&gt;
|&#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;&lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;11&#039;&#039;(8), 484–490&lt;br /&gt;
|https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Pediatric Cances&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Shohdy, K. S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &lt;br /&gt;
|&#039;&#039;Therapeutic Delivery&#039;&#039;&lt;br /&gt;
|2013&lt;br /&gt;
|&#039;&#039;4&#039;&#039;(9), 1197–1209&lt;br /&gt;
|https://doi.org/10.4155/tde.13.75&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Biology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Amgad, M., &amp;amp; &#039;&#039;&#039;AlFaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Integrating web 2.0 in clinical research education in a developing country.&lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;29&#039;&#039;(3), 536–540&lt;br /&gt;
|https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|Education&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Nour, R.&lt;br /&gt;
|What a reference manager can add for a physician in web 2.0 era.&lt;br /&gt;
|&#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;8&#039;&#039;(2), 55&lt;br /&gt;
|https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Clinical Research&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Orbital tumors in USA: Difference in survival patterns.&lt;br /&gt;
|&#039;&#039;Cancer Epidemiology&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(5), 515–522&lt;br /&gt;
|https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
|2.890&lt;br /&gt;
|Q3&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma.&lt;br /&gt;
|&#039;&#039;Fetal and Pediatric Pathology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 176–184.&lt;br /&gt;
|https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
|1.412&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney.&lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association between quality of clinical trials and human development index in heart failure using JADAD scale.&lt;br /&gt;
|&#039;&#039;Principles and Practice of Clinical Research&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;1&#039;&#039;(2), 40–46&lt;br /&gt;
|https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Clinical Researrch&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El-Nadi, E., Elzomor, H., Labib, R. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M.&lt;br /&gt;
|Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &lt;br /&gt;
|&#039;&#039;Journal of Solid Tumors&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;2&#039;&#039;(5), 94&lt;br /&gt;
|https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(4), 195–203&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of Orbit: Is it So Fatal?&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(6), 493&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Labib, R. M., Mostafa, M. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S.&lt;br /&gt;
|Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &lt;br /&gt;
|&#039;&#039;Biopreservation and Biobanking&#039;&#039;,&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;14&#039;&#039;(1), 9–16&lt;br /&gt;
|https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
|2.256&lt;br /&gt;
|Q3&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Clinical Research Recession: Training Needs Perception Among Medical Students. &lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;32&#039;&#039;(4), 728–733.&lt;br /&gt;
|https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|Education&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S.&lt;br /&gt;
|A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.&lt;br /&gt;
|&#039;&#039;International Ophthalmology&#039;&#039;&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(1), 111–118.&lt;br /&gt;
|https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
|2.029&lt;br /&gt;
|Q3&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|ElZomor H, Taha H, Aleieldin A, Nour R, Zaghloul MS, Fawzi M, Kamel A, Alfaar AS.&lt;br /&gt;
|High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|36(3):287-9&lt;br /&gt;
|https://10.3109/13816810.2015.1016241 &lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(4), 345–351.&lt;br /&gt;
|https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases.&lt;br /&gt;
|&#039;&#039;Cancer Medicine&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;6&#039;&#039;(7), 1817–1826.&lt;br /&gt;
|https://doi.org/10.1002/cam4.1122&lt;br /&gt;
|4.711&lt;br /&gt;
|Q2&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;39&#039;&#039;(2), 150–152.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000699&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Rashed, W. M.&lt;br /&gt;
|Risk of second malignancies among survivors of pediatric thyroid cancer.&lt;br /&gt;
|&#039;&#039;International Journal of Clinical Oncology&#039;&#039;,&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;23&#039;&#039;(4), 625–633.&lt;br /&gt;
|https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
|3.850&lt;br /&gt;
|Q3&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study.&lt;br /&gt;
|&#039;&#039;Endocrine Connections&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;7&#039;&#039;(10), 1040–1048.&lt;br /&gt;
|https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
|3.221&lt;br /&gt;
|Q3&lt;br /&gt;
|Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A.&lt;br /&gt;
|Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.&lt;br /&gt;
|&#039;&#039;International Journal of Neuroscience&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|129(5), 447-454&lt;br /&gt;
|https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
|2.590&lt;br /&gt;
|Q4&lt;br /&gt;
|Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Chamdine, O., Elhawary, G. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &lt;br /&gt;
|&#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 431–439&lt;br /&gt;
|https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
|1.532&lt;br /&gt;
|Q4&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Hamoda, H. M.&lt;br /&gt;
|Suicidal death within a year of a cancer diagnosis: A population-based study.&lt;br /&gt;
|&#039;&#039;Cancer&#039;&#039;&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;125&#039;&#039;(6), 972–979&lt;br /&gt;
|https://doi.org/10.1002/cncr.31876&lt;br /&gt;
|6.921&lt;br /&gt;
|Q1&lt;br /&gt;
|Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Reichhart, N., Schöberl, S., Keckeis, S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O.&lt;br /&gt;
|Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &lt;br /&gt;
|&#039;&#039;Scientific Reports&#039;&#039;,&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;9&#039;&#039;(1), 2257&lt;br /&gt;
|https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
|4.996&lt;br /&gt;
|Q2&lt;br /&gt;
|Biology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Cordes, M., Bucichowski, P., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O.&lt;br /&gt;
|Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells.&lt;br /&gt;
|&#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;May 2019&#039;&#039;, fj.201901202RR&lt;br /&gt;
|https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
|5.834&lt;br /&gt;
|Q1&lt;br /&gt;
|Biology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries.&lt;br /&gt;
|&#039;&#039;Pediatric Hematology and Oncology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|198-210&lt;br /&gt;
|https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
|2.070&lt;br /&gt;
|Q3&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|259, 515–526&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association of Brain Cancer With Risk of Suicide.&lt;br /&gt;
|&#039;&#039;JAMA Network Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;3&#039;&#039;(5), e203862&lt;br /&gt;
|https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
|13.353&lt;br /&gt;
|Q1&lt;br /&gt;
|Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients.&lt;br /&gt;
|&#039;&#039;Eye&#039;&#039;.&lt;br /&gt;
|2020&lt;br /&gt;
|35(9):2564-2572&lt;br /&gt;
|https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
|4.456&lt;br /&gt;
|Q1&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. &lt;br /&gt;
|Uveal melanoma-associated cancers revisited. &lt;br /&gt;
|&#039;&#039;ESMO Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;5&#039;&#039;(6), e000990.&lt;br /&gt;
|https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
|6.883&lt;br /&gt;
|Q1&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body.&lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. &lt;br /&gt;
|2020&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. &lt;br /&gt;
|Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.&lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;, 1–14&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|Ophthalmology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T.&lt;br /&gt;
|Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|Ophthalmology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hammad, M., Hosny, M., Khalil, E., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Fawzy, M.&lt;br /&gt;
|Pediatric ependymoma: A single-center experience from a developing country.&lt;br /&gt;
|&#039;&#039;Indian Journal of Cancer&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;55&#039;&#039;(1), 382–389&lt;br /&gt;
|https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
|1.397&lt;br /&gt;
|Q4&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M.&lt;br /&gt;
|The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2021&lt;br /&gt;
|260, pages1723–1731 &lt;br /&gt;
|https://doi.org/10.1007/s00417-021-05317-7&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS, Stürzbecher L, Diedrichs-Möhring M, Lam M, Roubeix C, Ritter J, Schumann K, Annamalai B, Pompös IM, Rohrer B, Sennlaub F, Reichhart N, Wildner G, Strauß O.&lt;br /&gt;
|FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration&lt;br /&gt;
|J Neuroinflammation&lt;br /&gt;
.&lt;br /&gt;
|2022&lt;br /&gt;
|19(1):260&lt;br /&gt;
|https://doi.org/10.1186/s12974-022-02620-w&lt;br /&gt;
|9.587&lt;br /&gt;
|Q1&lt;br /&gt;
|Biology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Abdelazeem B, Abbas KS, Shehata J, &#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS.&lt;br /&gt;
|Increased Risk of Subsequent Skin Melanoma in Patients with Retinoblastoma: SEER-Based Results.&lt;br /&gt;
|J Invest Dermatol.&lt;br /&gt;
|2022&lt;br /&gt;
|142(11):3123-3125&lt;br /&gt;
|https://doi.org/10.1016/j.jid.2022.04.013&lt;br /&gt;
|7.590&lt;br /&gt;
|Q1&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS, Suckert CN, Rehak M, Girbardt C.&lt;br /&gt;
|The epidemiology of adults&#039; eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients&#039; data.&lt;br /&gt;
|Eur J Ophthalmol&lt;br /&gt;
|2022&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1177/11206721221125018&lt;br /&gt;
|1.922&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Abdelazeem B, Abbas KS, Shehata J, El-Shahat NA, Eltaras MM, Qaddoumi I, &#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS.&lt;br /&gt;
|Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?&lt;br /&gt;
|Cancer Med&lt;br /&gt;
|2022 &lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1002/cam4.5406&lt;br /&gt;
|4.711&lt;br /&gt;
|Q2&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=61</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=61"/>
		<updated>2023-02-10T10:36:17Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: Added the themes column&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Authors&lt;br /&gt;
!Title&lt;br /&gt;
!Journal&lt;br /&gt;
!Online&lt;br /&gt;
!Volume, Issue, Pages&lt;br /&gt;
!DOI&lt;br /&gt;
!IF&lt;br /&gt;
!Rank&lt;br /&gt;
!Theme&lt;br /&gt;
!Submitted&lt;br /&gt;
!Accepted&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A.&lt;br /&gt;
|International telepharmacy education: another venue to improve cancer care in the developing world.&lt;br /&gt;
|&#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;18&#039;&#039;(6), 470–474.&lt;br /&gt;
|https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
|5.033&lt;br /&gt;
|Q1&lt;br /&gt;
|Education&lt;br /&gt;
|August 31, 2011&lt;br /&gt;
|November 29, 2011&lt;br /&gt;
|-&lt;br /&gt;
|Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., &#039;&#039;&#039;Samir&#039;&#039;&#039;, A., &amp;amp; Younes, A. A. &lt;br /&gt;
|Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &lt;br /&gt;
|&#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;&lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;11&#039;&#039;(8), 484–490&lt;br /&gt;
|https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Pediatric Cances&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Shohdy, K. S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &lt;br /&gt;
|&#039;&#039;Therapeutic Delivery&#039;&#039;&lt;br /&gt;
|2013&lt;br /&gt;
|&#039;&#039;4&#039;&#039;(9), 1197–1209&lt;br /&gt;
|https://doi.org/10.4155/tde.13.75&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Biology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Amgad, M., &amp;amp; &#039;&#039;&#039;AlFaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Integrating web 2.0 in clinical research education in a developing country.&lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;29&#039;&#039;(3), 536–540&lt;br /&gt;
|https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|Education&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Nour, R.&lt;br /&gt;
|What a reference manager can add for a physician in web 2.0 era.&lt;br /&gt;
|&#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;8&#039;&#039;(2), 55&lt;br /&gt;
|https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Clinical Research&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Orbital tumors in USA: Difference in survival patterns.&lt;br /&gt;
|&#039;&#039;Cancer Epidemiology&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(5), 515–522&lt;br /&gt;
|https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
|2.890&lt;br /&gt;
|Q3&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma.&lt;br /&gt;
|&#039;&#039;Fetal and Pediatric Pathology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 176–184.&lt;br /&gt;
|https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
|1.412&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney.&lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association between quality of clinical trials and human development index in heart failure using JADAD scale.&lt;br /&gt;
|&#039;&#039;Principles and Practice of Clinical Research&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;1&#039;&#039;(2), 40–46&lt;br /&gt;
|https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Clinical Researrch&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El-Nadi, E., Elzomor, H., Labib, R. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M.&lt;br /&gt;
|Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &lt;br /&gt;
|&#039;&#039;Journal of Solid Tumors&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;2&#039;&#039;(5), 94&lt;br /&gt;
|https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(4), 195–203&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of Orbit: Is it So Fatal?&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(6), 493&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Labib, R. M., Mostafa, M. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S.&lt;br /&gt;
|Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &lt;br /&gt;
|&#039;&#039;Biopreservation and Biobanking&#039;&#039;,&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;14&#039;&#039;(1), 9–16&lt;br /&gt;
|https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
|2.256&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Clinical Research Recession: Training Needs Perception Among Medical Students. &lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;32&#039;&#039;(4), 728–733.&lt;br /&gt;
|https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|Education&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S.&lt;br /&gt;
|A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.&lt;br /&gt;
|&#039;&#039;International Ophthalmology&#039;&#039;&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(1), 111–118.&lt;br /&gt;
|https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
|2.029&lt;br /&gt;
|Q3&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|ElZomor H, Taha H, Aleieldin A, Nour R, Zaghloul MS, Fawzi M, Kamel A, Alfaar AS.&lt;br /&gt;
|High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|36(3):287-9&lt;br /&gt;
|https://10.3109/13816810.2015.1016241 &lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(4), 345–351.&lt;br /&gt;
|https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases.&lt;br /&gt;
|&#039;&#039;Cancer Medicine&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;6&#039;&#039;(7), 1817–1826.&lt;br /&gt;
|https://doi.org/10.1002/cam4.1122&lt;br /&gt;
|4.711&lt;br /&gt;
|Q2&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;39&#039;&#039;(2), 150–152.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000699&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Rashed, W. M.&lt;br /&gt;
|Risk of second malignancies among survivors of pediatric thyroid cancer.&lt;br /&gt;
|&#039;&#039;International Journal of Clinical Oncology&#039;&#039;,&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;23&#039;&#039;(4), 625–633.&lt;br /&gt;
|https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
|3.850&lt;br /&gt;
|Q3&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study.&lt;br /&gt;
|&#039;&#039;Endocrine Connections&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;7&#039;&#039;(10), 1040–1048.&lt;br /&gt;
|https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
|3.221&lt;br /&gt;
|Q3&lt;br /&gt;
|Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A.&lt;br /&gt;
|Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.&lt;br /&gt;
|&#039;&#039;International Journal of Neuroscience&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|129(5), 447-454&lt;br /&gt;
|https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
|2.590&lt;br /&gt;
|Q4&lt;br /&gt;
|Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Chamdine, O., Elhawary, G. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &lt;br /&gt;
|&#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 431–439&lt;br /&gt;
|https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
|1.532&lt;br /&gt;
|Q4&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Hamoda, H. M.&lt;br /&gt;
|Suicidal death within a year of a cancer diagnosis: A population-based study.&lt;br /&gt;
|&#039;&#039;Cancer&#039;&#039;&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;125&#039;&#039;(6), 972–979&lt;br /&gt;
|https://doi.org/10.1002/cncr.31876&lt;br /&gt;
|6.921&lt;br /&gt;
|Q1&lt;br /&gt;
|Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Reichhart, N., Schöberl, S., Keckeis, S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O.&lt;br /&gt;
|Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &lt;br /&gt;
|&#039;&#039;Scientific Reports&#039;&#039;,&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;9&#039;&#039;(1), 2257&lt;br /&gt;
|https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
|4.996&lt;br /&gt;
|Q2&lt;br /&gt;
|Biology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Cordes, M., Bucichowski, P., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O.&lt;br /&gt;
|Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells.&lt;br /&gt;
|&#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;May 2019&#039;&#039;, fj.201901202RR&lt;br /&gt;
|https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
|5.834&lt;br /&gt;
|Q1&lt;br /&gt;
|Biology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries.&lt;br /&gt;
|&#039;&#039;Pediatric Hematology and Oncology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|198-210&lt;br /&gt;
|https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
|2.070&lt;br /&gt;
|Q3&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|259, 515–526&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association of Brain Cancer With Risk of Suicide.&lt;br /&gt;
|&#039;&#039;JAMA Network Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;3&#039;&#039;(5), e203862&lt;br /&gt;
|https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
|13.353&lt;br /&gt;
|Q1&lt;br /&gt;
|Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients.&lt;br /&gt;
|&#039;&#039;Eye&#039;&#039;.&lt;br /&gt;
|2020&lt;br /&gt;
|35(9):2564-2572&lt;br /&gt;
|https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
|4.456&lt;br /&gt;
|Q1&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. &lt;br /&gt;
|Uveal melanoma-associated cancers revisited. &lt;br /&gt;
|&#039;&#039;ESMO Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;5&#039;&#039;(6), e000990.&lt;br /&gt;
|https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
|6.883&lt;br /&gt;
|Q1&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body.&lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. &lt;br /&gt;
|2020&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. &lt;br /&gt;
|Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.&lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;, 1–14&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|Ophthalmology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T.&lt;br /&gt;
|Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|Ophthalmology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hammad, M., Hosny, M., Khalil, E., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Fawzy, M.&lt;br /&gt;
|Pediatric ependymoma: A single-center experience from a developing country.&lt;br /&gt;
|&#039;&#039;Indian Journal of Cancer&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;55&#039;&#039;(1), 382–389&lt;br /&gt;
|https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
|1.397&lt;br /&gt;
|Q4&lt;br /&gt;
|Pediatric Oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M.&lt;br /&gt;
|The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2021&lt;br /&gt;
|260, pages1723–1731 &lt;br /&gt;
|https://doi.org/10.1007/s00417-021-05317-7&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS, Stürzbecher L, Diedrichs-Möhring M, Lam M, Roubeix C, Ritter J, Schumann K, Annamalai B, Pompös IM, Rohrer B, Sennlaub F, Reichhart N, Wildner G, Strauß O.&lt;br /&gt;
|FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration&lt;br /&gt;
|J Neuroinflammation&lt;br /&gt;
.&lt;br /&gt;
|2022&lt;br /&gt;
|19(1):260&lt;br /&gt;
|https://doi.org/10.1186/s12974-022-02620-w&lt;br /&gt;
|9.587&lt;br /&gt;
|Q1&lt;br /&gt;
|Biology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Abdelazeem B, Abbas KS, Shehata J, &#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS.&lt;br /&gt;
|Increased Risk of Subsequent Skin Melanoma in Patients with Retinoblastoma: SEER-Based Results.&lt;br /&gt;
|J Invest Dermatol.&lt;br /&gt;
|2022&lt;br /&gt;
|142(11):3123-3125&lt;br /&gt;
|https://doi.org/10.1016/j.jid.2022.04.013&lt;br /&gt;
|7.590&lt;br /&gt;
|Q1&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS, Suckert CN, Rehak M, Girbardt C.&lt;br /&gt;
|The epidemiology of adults&#039; eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients&#039; data.&lt;br /&gt;
|Eur J Ophthalmol&lt;br /&gt;
|2022&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1177/11206721221125018&lt;br /&gt;
|1.922&lt;br /&gt;
|Q4&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Abdelazeem B, Abbas KS, Shehata J, El-Shahat NA, Eltaras MM, Qaddoumi I, &#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS.&lt;br /&gt;
|Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?&lt;br /&gt;
|Cancer Med&lt;br /&gt;
|2022 &lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1002/cam4.5406&lt;br /&gt;
|4.711&lt;br /&gt;
|Q2&lt;br /&gt;
|Ocular oncology&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=60</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=60"/>
		<updated>2022-12-24T23:43:38Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Authors&lt;br /&gt;
!Title&lt;br /&gt;
!Journal&lt;br /&gt;
!Online&lt;br /&gt;
!Volume, Issue, Pages&lt;br /&gt;
!DOI&lt;br /&gt;
!IF&lt;br /&gt;
!Rank&lt;br /&gt;
!Submitted&lt;br /&gt;
!Accepted&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A.&lt;br /&gt;
|International telepharmacy education: another venue to improve cancer care in the developing world.&lt;br /&gt;
|&#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;18&#039;&#039;(6), 470–474.&lt;br /&gt;
|https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
|5.033&lt;br /&gt;
|Q1&lt;br /&gt;
|August 31, 2011&lt;br /&gt;
|November 29, 2011&lt;br /&gt;
|-&lt;br /&gt;
|Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., &#039;&#039;&#039;Samir&#039;&#039;&#039;, A., &amp;amp; Younes, A. A. &lt;br /&gt;
|Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &lt;br /&gt;
|&#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;&lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;11&#039;&#039;(8), 484–490&lt;br /&gt;
|https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Shohdy, K. S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &lt;br /&gt;
|&#039;&#039;Therapeutic Delivery&#039;&#039;&lt;br /&gt;
|2013&lt;br /&gt;
|&#039;&#039;4&#039;&#039;(9), 1197–1209&lt;br /&gt;
|https://doi.org/10.4155/tde.13.75&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Amgad, M., &amp;amp; &#039;&#039;&#039;AlFaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Integrating web 2.0 in clinical research education in a developing country.&lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;29&#039;&#039;(3), 536–540&lt;br /&gt;
|https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Nour, R.&lt;br /&gt;
|What a reference manager can add for a physician in web 2.0 era.&lt;br /&gt;
|&#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;8&#039;&#039;(2), 55&lt;br /&gt;
|https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Orbital tumors in USA: Difference in survival patterns.&lt;br /&gt;
|&#039;&#039;Cancer Epidemiology&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(5), 515–522&lt;br /&gt;
|https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
|2.890&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma.&lt;br /&gt;
|&#039;&#039;Fetal and Pediatric Pathology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 176–184.&lt;br /&gt;
|https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
|1.412&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney.&lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association between quality of clinical trials and human development index in heart failure using JADAD scale.&lt;br /&gt;
|&#039;&#039;Principles and Practice of Clinical Research&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;1&#039;&#039;(2), 40–46&lt;br /&gt;
|https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El-Nadi, E., Elzomor, H., Labib, R. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M.&lt;br /&gt;
|Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &lt;br /&gt;
|&#039;&#039;Journal of Solid Tumors&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;2&#039;&#039;(5), 94&lt;br /&gt;
|https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(4), 195–203&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of Orbit: Is it So Fatal?&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(6), 493&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Labib, R. M., Mostafa, M. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S.&lt;br /&gt;
|Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &lt;br /&gt;
|&#039;&#039;Biopreservation and Biobanking&#039;&#039;,&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;14&#039;&#039;(1), 9–16&lt;br /&gt;
|https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
|2.256&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Clinical Research Recession: Training Needs Perception Among Medical Students. &lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;32&#039;&#039;(4), 728–733.&lt;br /&gt;
|https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S.&lt;br /&gt;
|A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.&lt;br /&gt;
|&#039;&#039;International Ophthalmology&#039;&#039;&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(1), 111–118.&lt;br /&gt;
|https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
|2.029&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|ElZomor H, Taha H, Aleieldin A, Nour R, Zaghloul MS, Fawzi M, Kamel A, Alfaar AS.&lt;br /&gt;
|High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|36(3):287-9&lt;br /&gt;
|https://10.3109/13816810.2015.1016241 &lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(4), 345–351.&lt;br /&gt;
|https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases.&lt;br /&gt;
|&#039;&#039;Cancer Medicine&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;6&#039;&#039;(7), 1817–1826.&lt;br /&gt;
|https://doi.org/10.1002/cam4.1122&lt;br /&gt;
|4.711&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;39&#039;&#039;(2), 150–152.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000699&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Rashed, W. M.&lt;br /&gt;
|Risk of second malignancies among survivors of pediatric thyroid cancer.&lt;br /&gt;
|&#039;&#039;International Journal of Clinical Oncology&#039;&#039;,&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;23&#039;&#039;(4), 625–633.&lt;br /&gt;
|https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
|3.850&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study.&lt;br /&gt;
|&#039;&#039;Endocrine Connections&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;7&#039;&#039;(10), 1040–1048.&lt;br /&gt;
|https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
|3.221&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A.&lt;br /&gt;
|Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.&lt;br /&gt;
|&#039;&#039;International Journal of Neuroscience&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|129(5), 447-454&lt;br /&gt;
|https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
|2.590&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Chamdine, O., Elhawary, G. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &lt;br /&gt;
|&#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 431–439&lt;br /&gt;
|https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
|1.532&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Hamoda, H. M.&lt;br /&gt;
|Suicidal death within a year of a cancer diagnosis: A population-based study.&lt;br /&gt;
|&#039;&#039;Cancer&#039;&#039;&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;125&#039;&#039;(6), 972–979&lt;br /&gt;
|https://doi.org/10.1002/cncr.31876&lt;br /&gt;
|6.921&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Reichhart, N., Schöberl, S., Keckeis, S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O.&lt;br /&gt;
|Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &lt;br /&gt;
|&#039;&#039;Scientific Reports&#039;&#039;,&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;9&#039;&#039;(1), 2257&lt;br /&gt;
|https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
|4.996&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Cordes, M., Bucichowski, P., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O.&lt;br /&gt;
|Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells.&lt;br /&gt;
|&#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;May 2019&#039;&#039;, fj.201901202RR&lt;br /&gt;
|https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
|5.834&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries.&lt;br /&gt;
|&#039;&#039;Pediatric Hematology and Oncology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|198-210&lt;br /&gt;
|https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
|2.070&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|259, 515–526&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association of Brain Cancer With Risk of Suicide.&lt;br /&gt;
|&#039;&#039;JAMA Network Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;3&#039;&#039;(5), e203862&lt;br /&gt;
|https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
|13.353&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients.&lt;br /&gt;
|&#039;&#039;Eye&#039;&#039;.&lt;br /&gt;
|2020&lt;br /&gt;
|35(9):2564-2572&lt;br /&gt;
|https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
|4.456&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. &lt;br /&gt;
|Uveal melanoma-associated cancers revisited. &lt;br /&gt;
|&#039;&#039;ESMO Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;5&#039;&#039;(6), e000990.&lt;br /&gt;
|https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
|6.883&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body.&lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. &lt;br /&gt;
|2020&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. &lt;br /&gt;
|Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.&lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;, 1–14&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T.&lt;br /&gt;
|Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hammad, M., Hosny, M., Khalil, E., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Fawzy, M.&lt;br /&gt;
|Pediatric ependymoma: A single-center experience from a developing country.&lt;br /&gt;
|&#039;&#039;Indian Journal of Cancer&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;55&#039;&#039;(1), 382–389&lt;br /&gt;
|https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
|1.397&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M.&lt;br /&gt;
|The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2021&lt;br /&gt;
|260, pages1723–1731 &lt;br /&gt;
|https://doi.org/10.1007/s00417-021-05317-7&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS, Stürzbecher L, Diedrichs-Möhring M, Lam M, Roubeix C, Ritter J, Schumann K, Annamalai B, Pompös IM, Rohrer B, Sennlaub F, Reichhart N, Wildner G, Strauß O.&lt;br /&gt;
|FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration&lt;br /&gt;
|J Neuroinflammation&lt;br /&gt;
.&lt;br /&gt;
|2022&lt;br /&gt;
|19(1):260&lt;br /&gt;
|https://doi.org/10.1186/s12974-022-02620-w&lt;br /&gt;
|9.587&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Abdelazeem B, Abbas KS, Shehata J, &#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS.&lt;br /&gt;
|Increased Risk of Subsequent Skin Melanoma in Patients with Retinoblastoma: SEER-Based Results.&lt;br /&gt;
|J Invest Dermatol.&lt;br /&gt;
|2022&lt;br /&gt;
|142(11):3123-3125&lt;br /&gt;
|https://doi.org/10.1016/j.jid.2022.04.013&lt;br /&gt;
|7.590&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS, Suckert CN, Rehak M, Girbardt C.&lt;br /&gt;
|The epidemiology of adults&#039; eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients&#039; data.&lt;br /&gt;
|Eur J Ophthalmol&lt;br /&gt;
|2022&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1177/11206721221125018&lt;br /&gt;
|1.922&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Abdelazeem B, Abbas KS, Shehata J, El-Shahat NA, Eltaras MM, Qaddoumi I, &#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS.&lt;br /&gt;
|Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?&lt;br /&gt;
|Cancer Med&lt;br /&gt;
|2022 &lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1002/cam4.5406&lt;br /&gt;
|4.711&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=59</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=59"/>
		<updated>2022-12-24T23:41:29Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Authors&lt;br /&gt;
!Title&lt;br /&gt;
!Journal&lt;br /&gt;
!Online&lt;br /&gt;
!Volume, Issue, Pages&lt;br /&gt;
!DOI&lt;br /&gt;
!IF&lt;br /&gt;
!Rank&lt;br /&gt;
!Submitted&lt;br /&gt;
!Accepted&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A.&lt;br /&gt;
|International telepharmacy education: another venue to improve cancer care in the developing world.&lt;br /&gt;
|&#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;18&#039;&#039;(6), 470–474.&lt;br /&gt;
|https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
|5.033&lt;br /&gt;
|Q1&lt;br /&gt;
|August 31, 2011&lt;br /&gt;
|November 29, 2011&lt;br /&gt;
|-&lt;br /&gt;
|Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., &#039;&#039;&#039;Samir&#039;&#039;&#039;, A., &amp;amp; Younes, A. A. &lt;br /&gt;
|Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &lt;br /&gt;
|&#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;&lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;11&#039;&#039;(8), 484–490&lt;br /&gt;
|https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Shohdy, K. S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &lt;br /&gt;
|&#039;&#039;Therapeutic Delivery&#039;&#039;&lt;br /&gt;
|2013&lt;br /&gt;
|&#039;&#039;4&#039;&#039;(9), 1197–1209&lt;br /&gt;
|https://doi.org/10.4155/tde.13.75&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Amgad, M., &amp;amp; &#039;&#039;&#039;AlFaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Integrating web 2.0 in clinical research education in a developing country.&lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;29&#039;&#039;(3), 536–540&lt;br /&gt;
|https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Nour, R.&lt;br /&gt;
|What a reference manager can add for a physician in web 2.0 era.&lt;br /&gt;
|&#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;8&#039;&#039;(2), 55&lt;br /&gt;
|https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Orbital tumors in USA: Difference in survival patterns.&lt;br /&gt;
|&#039;&#039;Cancer Epidemiology&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(5), 515–522&lt;br /&gt;
|https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
|2.890&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma.&lt;br /&gt;
|&#039;&#039;Fetal and Pediatric Pathology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 176–184.&lt;br /&gt;
|https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
|1.412&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney.&lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association between quality of clinical trials and human development index in heart failure using JADAD scale.&lt;br /&gt;
|&#039;&#039;Principles and Practice of Clinical Research&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;1&#039;&#039;(2), 40–46&lt;br /&gt;
|https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El-Nadi, E., Elzomor, H., Labib, R. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M.&lt;br /&gt;
|Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &lt;br /&gt;
|&#039;&#039;Journal of Solid Tumors&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;2&#039;&#039;(5), 94&lt;br /&gt;
|https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(4), 195–203&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of Orbit: Is it So Fatal?&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(6), 493&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Labib, R. M., Mostafa, M. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S.&lt;br /&gt;
|Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &lt;br /&gt;
|&#039;&#039;Biopreservation and Biobanking&#039;&#039;,&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;14&#039;&#039;(1), 9–16&lt;br /&gt;
|https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
|2.256&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Clinical Research Recession: Training Needs Perception Among Medical Students. &lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;32&#039;&#039;(4), 728–733.&lt;br /&gt;
|https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S.&lt;br /&gt;
|A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.&lt;br /&gt;
|&#039;&#039;International Ophthalmology&#039;&#039;&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(1), 111–118.&lt;br /&gt;
|https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
|2.029&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|ElZomor H, Taha H, Aleieldin A, Nour R, Zaghloul MS, Fawzi M, Kamel A, Alfaar AS.&lt;br /&gt;
|High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|36(3):287-9&lt;br /&gt;
|https://10.3109/13816810.2015.1016241 &lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(4), 345–351.&lt;br /&gt;
|https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases.&lt;br /&gt;
|&#039;&#039;Cancer Medicine&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;6&#039;&#039;(7), 1817–1826.&lt;br /&gt;
|https://doi.org/10.1002/cam4.1122&lt;br /&gt;
|4.711&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;39&#039;&#039;(2), 150–152.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000699&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Rashed, W. M.&lt;br /&gt;
|Risk of second malignancies among survivors of pediatric thyroid cancer.&lt;br /&gt;
|&#039;&#039;International Journal of Clinical Oncology&#039;&#039;,&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;23&#039;&#039;(4), 625–633.&lt;br /&gt;
|https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
|3.850&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study.&lt;br /&gt;
|&#039;&#039;Endocrine Connections&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;7&#039;&#039;(10), 1040–1048.&lt;br /&gt;
|https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
|3.221&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A.&lt;br /&gt;
|Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.&lt;br /&gt;
|&#039;&#039;International Journal of Neuroscience&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|129(5), 447-454&lt;br /&gt;
|https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
|2.590&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Chamdine, O., Elhawary, G. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &lt;br /&gt;
|&#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 431–439&lt;br /&gt;
|https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
|1.532&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Hamoda, H. M.&lt;br /&gt;
|Suicidal death within a year of a cancer diagnosis: A population-based study.&lt;br /&gt;
|&#039;&#039;Cancer&#039;&#039;&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;125&#039;&#039;(6), 972–979&lt;br /&gt;
|https://doi.org/10.1002/cncr.31876&lt;br /&gt;
|6.921&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Reichhart, N., Schöberl, S., Keckeis, S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O.&lt;br /&gt;
|Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &lt;br /&gt;
|&#039;&#039;Scientific Reports&#039;&#039;,&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;9&#039;&#039;(1), 2257&lt;br /&gt;
|https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
|4.996&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Cordes, M., Bucichowski, P., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O.&lt;br /&gt;
|Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells.&lt;br /&gt;
|&#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;May 2019&#039;&#039;, fj.201901202RR&lt;br /&gt;
|https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
|5.834&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries.&lt;br /&gt;
|&#039;&#039;Pediatric Hematology and Oncology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|198-210&lt;br /&gt;
|https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
|2.070&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|259, 515–526&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association of Brain Cancer With Risk of Suicide.&lt;br /&gt;
|&#039;&#039;JAMA Network Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;3&#039;&#039;(5), e203862&lt;br /&gt;
|https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
|13.353&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients.&lt;br /&gt;
|&#039;&#039;Eye&#039;&#039;.&lt;br /&gt;
|2020&lt;br /&gt;
|35(9):2564-2572&lt;br /&gt;
|https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
|4.456&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. &lt;br /&gt;
|Uveal melanoma-associated cancers revisited. &lt;br /&gt;
|&#039;&#039;ESMO Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;5&#039;&#039;(6), e000990.&lt;br /&gt;
|https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
|6.883&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body.&lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. &lt;br /&gt;
|2020&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. &lt;br /&gt;
|Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.&lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;, 1–14&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T.&lt;br /&gt;
|Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hammad, M., Hosny, M., Khalil, E., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Fawzy, M.&lt;br /&gt;
|Pediatric ependymoma: A single-center experience from a developing country.&lt;br /&gt;
|&#039;&#039;Indian Journal of Cancer&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;55&#039;&#039;(1), 382–389&lt;br /&gt;
|https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
|1.397&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M.&lt;br /&gt;
|The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2021&lt;br /&gt;
|260, pages1723–1731 &lt;br /&gt;
|https://doi.org/10.1007/s00417-021-05317-7&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS, Stürzbecher L, Diedrichs-Möhring M, Lam M, Roubeix C, Ritter J, Schumann K, Annamalai B, Pompös IM, Rohrer B, Sennlaub F, Reichhart N, Wildner G, Strauß O.&lt;br /&gt;
|FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration&lt;br /&gt;
|J Neuroinflammation&lt;br /&gt;
.&lt;br /&gt;
|2022&lt;br /&gt;
|19(1):260&lt;br /&gt;
|https://doi.org/10.1186/s12974-022-02620-w&lt;br /&gt;
|9.587&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Abdelazeem B, Abbas KS, Shehata J, &#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS.&lt;br /&gt;
|Increased Risk of Subsequent Skin Melanoma in Patients with Retinoblastoma: SEER-Based Results.&lt;br /&gt;
|J Invest Dermatol.&lt;br /&gt;
|2022&lt;br /&gt;
|142(11):3123-3125&lt;br /&gt;
|https://doi.org/10.1016/j.jid.2022.04.013&lt;br /&gt;
|7.590&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS, Suckert CN, Rehak M, Girbardt C.&lt;br /&gt;
|The epidemiology of adults&#039; eyelid malignancies in Germany between 2009 and 2015; An analysis of 42,710 patients&#039; data.&lt;br /&gt;
|Eur J Ophthalmol&lt;br /&gt;
|2022&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1177/11206721221125018&lt;br /&gt;
|1.922&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Abdelazeem&#039;&#039;&#039; B, Abbas KS, Shehata J, El-Shahat NA, Eltaras MM, Qaddoumi I, Alfaar AS.&lt;br /&gt;
|Survival trends for patients with retinoblastoma between 2000 and 2018: What has changed?&lt;br /&gt;
|Cancer Med&lt;br /&gt;
|2022 &lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1002/cam4.5406&lt;br /&gt;
|4.711&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=58</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=58"/>
		<updated>2022-12-24T23:36:55Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Authors&lt;br /&gt;
!Title&lt;br /&gt;
!Journal&lt;br /&gt;
!Online&lt;br /&gt;
!Volume, Issue, Pages&lt;br /&gt;
!DOI&lt;br /&gt;
!IF&lt;br /&gt;
!Rank&lt;br /&gt;
!Submitted&lt;br /&gt;
!Accepted&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A.&lt;br /&gt;
|International telepharmacy education: another venue to improve cancer care in the developing world.&lt;br /&gt;
|&#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;18&#039;&#039;(6), 470–474.&lt;br /&gt;
|https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
|5.033&lt;br /&gt;
|Q1&lt;br /&gt;
|August 31, 2011&lt;br /&gt;
|November 29, 2011&lt;br /&gt;
|-&lt;br /&gt;
|Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., &#039;&#039;&#039;Samir&#039;&#039;&#039;, A., &amp;amp; Younes, A. A. &lt;br /&gt;
|Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &lt;br /&gt;
|&#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;&lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;11&#039;&#039;(8), 484–490&lt;br /&gt;
|https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Shohdy, K. S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &lt;br /&gt;
|&#039;&#039;Therapeutic Delivery&#039;&#039;&lt;br /&gt;
|2013&lt;br /&gt;
|&#039;&#039;4&#039;&#039;(9), 1197–1209&lt;br /&gt;
|https://doi.org/10.4155/tde.13.75&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Amgad, M., &amp;amp; &#039;&#039;&#039;AlFaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Integrating web 2.0 in clinical research education in a developing country.&lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;29&#039;&#039;(3), 536–540&lt;br /&gt;
|https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Nour, R.&lt;br /&gt;
|What a reference manager can add for a physician in web 2.0 era.&lt;br /&gt;
|&#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;8&#039;&#039;(2), 55&lt;br /&gt;
|https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Orbital tumors in USA: Difference in survival patterns.&lt;br /&gt;
|&#039;&#039;Cancer Epidemiology&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(5), 515–522&lt;br /&gt;
|https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
|2.890&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma.&lt;br /&gt;
|&#039;&#039;Fetal and Pediatric Pathology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 176–184.&lt;br /&gt;
|https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
|1.412&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney.&lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association between quality of clinical trials and human development index in heart failure using JADAD scale.&lt;br /&gt;
|&#039;&#039;Principles and Practice of Clinical Research&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;1&#039;&#039;(2), 40–46&lt;br /&gt;
|https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El-Nadi, E., Elzomor, H., Labib, R. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M.&lt;br /&gt;
|Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &lt;br /&gt;
|&#039;&#039;Journal of Solid Tumors&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;2&#039;&#039;(5), 94&lt;br /&gt;
|https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(4), 195–203&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
| -&lt;br /&gt;
| -&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of Orbit: Is it So Fatal?&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(6), 493&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Labib, R. M., Mostafa, M. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S.&lt;br /&gt;
|Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &lt;br /&gt;
|&#039;&#039;Biopreservation and Biobanking&#039;&#039;,&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;14&#039;&#039;(1), 9–16&lt;br /&gt;
|https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
|2.256&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Clinical Research Recession: Training Needs Perception Among Medical Students. &lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;32&#039;&#039;(4), 728–733.&lt;br /&gt;
|https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
|1.771&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S.&lt;br /&gt;
|A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.&lt;br /&gt;
|&#039;&#039;International Ophthalmology&#039;&#039;&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(1), 111–118.&lt;br /&gt;
|https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
|2.029&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|ElZomor H, Taha H, Aleieldin A, Nour R, Zaghloul MS, Fawzi M, Kamel A, Alfaar AS.&lt;br /&gt;
|High Risk Retinoblastoma: Prevalence and Success of Treatment in Developing Countries.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|36(3):287-9&lt;br /&gt;
|https://10.3109/13816810.2015.1016241 &lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(4), 345–351.&lt;br /&gt;
|https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
|1.274&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases.&lt;br /&gt;
|&#039;&#039;Cancer Medicine&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;6&#039;&#039;(7), 1817–1826.&lt;br /&gt;
|https://doi.org/10.1002/cam4.1122&lt;br /&gt;
|4.711&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;39&#039;&#039;(2), 150–152.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000699&lt;br /&gt;
|1.170&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Rashed, W. M.&lt;br /&gt;
|Risk of second malignancies among survivors of pediatric thyroid cancer.&lt;br /&gt;
|&#039;&#039;International Journal of Clinical Oncology&#039;&#039;,&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;23&#039;&#039;(4), 625–633.&lt;br /&gt;
|https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
|3.850&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study.&lt;br /&gt;
|&#039;&#039;Endocrine Connections&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;7&#039;&#039;(10), 1040–1048.&lt;br /&gt;
|https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
|3.221&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A.&lt;br /&gt;
|Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.&lt;br /&gt;
|&#039;&#039;International Journal of Neuroscience&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|129(5), 447-454&lt;br /&gt;
|https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
|2.590&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Chamdine, O., Elhawary, G. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &lt;br /&gt;
|&#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 431–439&lt;br /&gt;
|https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
|1.532&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Hamoda, H. M.&lt;br /&gt;
|Suicidal death within a year of a cancer diagnosis: A population-based study.&lt;br /&gt;
|&#039;&#039;Cancer&#039;&#039;&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;125&#039;&#039;(6), 972–979&lt;br /&gt;
|https://doi.org/10.1002/cncr.31876&lt;br /&gt;
|6.921&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Reichhart, N., Schöberl, S., Keckeis, S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O.&lt;br /&gt;
|Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &lt;br /&gt;
|&#039;&#039;Scientific Reports&#039;&#039;,&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;9&#039;&#039;(1), 2257&lt;br /&gt;
|https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
|4.996&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Cordes, M., Bucichowski, P., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O.&lt;br /&gt;
|Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells.&lt;br /&gt;
|&#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;May 2019&#039;&#039;, fj.201901202RR&lt;br /&gt;
|https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
|5.834&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries.&lt;br /&gt;
|&#039;&#039;Pediatric Hematology and Oncology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|198-210&lt;br /&gt;
|https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
|2.070&lt;br /&gt;
|Q3&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|259, 515–526&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association of Brain Cancer With Risk of Suicide.&lt;br /&gt;
|&#039;&#039;JAMA Network Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;3&#039;&#039;(5), e203862&lt;br /&gt;
|https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
|13.353&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients.&lt;br /&gt;
|&#039;&#039;Eye&#039;&#039;.&lt;br /&gt;
|2020&lt;br /&gt;
|35(9):2564-2572&lt;br /&gt;
|https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
|4.456&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. &lt;br /&gt;
|Uveal melanoma-associated cancers revisited. &lt;br /&gt;
|&#039;&#039;ESMO Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;5&#039;&#039;(6), e000990.&lt;br /&gt;
|https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
|6.883&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body.&lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. &lt;br /&gt;
|2020&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. &lt;br /&gt;
|Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.&lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;, 1–14&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T.&lt;br /&gt;
|Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
|38.927&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hammad, M., Hosny, M., Khalil, E., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Fawzy, M.&lt;br /&gt;
|Pediatric ependymoma: A single-center experience from a developing country.&lt;br /&gt;
|&#039;&#039;Indian Journal of Cancer&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;55&#039;&#039;(1), 382–389&lt;br /&gt;
|https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
|1.397&lt;br /&gt;
|Q4&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M.&lt;br /&gt;
|The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2021&lt;br /&gt;
|260, pages1723–1731 &lt;br /&gt;
|https://doi.org/10.1007/s00417-021-05317-7&lt;br /&gt;
|3.535&lt;br /&gt;
|Q2&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039; AS, Stürzbecher L, Diedrichs-Möhring M, Lam M, Roubeix C, Ritter J, Schumann K, Annamalai B, Pompös IM, Rohrer B, Sennlaub F, Reichhart N, Wildner G, Strauß O.&lt;br /&gt;
|FoxP3 expression by retinal pigment epithelial cells: transcription factor with potential relevance for the pathology of age-related macular degeneration&lt;br /&gt;
|J Neuroinflammation&lt;br /&gt;
.&lt;br /&gt;
|2022&lt;br /&gt;
|19(1):260&lt;br /&gt;
|https://doi.org/10.1186/s12974-022-02620-w&lt;br /&gt;
|9.587&lt;br /&gt;
|Q1&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=57</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=57"/>
		<updated>2022-12-24T22:50:48Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Authors&lt;br /&gt;
!Title&lt;br /&gt;
!Journal&lt;br /&gt;
!Online&lt;br /&gt;
!Volume, Issue, Pages&lt;br /&gt;
!DOI&lt;br /&gt;
!IF&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A.&lt;br /&gt;
|International telepharmacy education: another venue to improve cancer care in the developing world.&lt;br /&gt;
|&#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;18&#039;&#039;(6), 470–474.&lt;br /&gt;
|https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., &#039;&#039;&#039;Samir&#039;&#039;&#039;, A., &amp;amp; Younes, A. A. &lt;br /&gt;
|Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &lt;br /&gt;
|&#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;&lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;11&#039;&#039;(8), 484–490&lt;br /&gt;
|https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Shohdy, K. S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &lt;br /&gt;
|&#039;&#039;Therapeutic Delivery&#039;&#039;&lt;br /&gt;
|2013&lt;br /&gt;
|&#039;&#039;4&#039;&#039;(9), 1197–1209&lt;br /&gt;
|https://doi.org/10.4155/tde.13.75&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Amgad, M., &amp;amp; &#039;&#039;&#039;AlFaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Integrating web 2.0 in clinical research education in a developing country.&lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;29&#039;&#039;(3), 536–540&lt;br /&gt;
|https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Nour, R.&lt;br /&gt;
|What a reference manager can add for a physician in web 2.0 era.&lt;br /&gt;
|&#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;8&#039;&#039;(2), 55&lt;br /&gt;
|https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Orbital tumors in USA: Difference in survival patterns.&lt;br /&gt;
|&#039;&#039;Cancer Epidemiology&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(5), 515–522&lt;br /&gt;
|https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma.&lt;br /&gt;
|&#039;&#039;Fetal and Pediatric Pathology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 176–184.&lt;br /&gt;
|https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney.&lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N.&lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association between quality of clinical trials and human development index in heart failure using JADAD scale.&lt;br /&gt;
|&#039;&#039;Principles and Practice of Clinical Research&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;1&#039;&#039;(2), 40–46&lt;br /&gt;
|https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El-Nadi, E., Elzomor, H., Labib, R. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M.&lt;br /&gt;
|Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &lt;br /&gt;
|&#039;&#039;Journal of Solid Tumors&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;2&#039;&#039;(5), 94&lt;br /&gt;
|https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(4), 195–203&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of Orbit: Is it So Fatal?&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(6), 493&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Labib, R. M., Mostafa, M. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S.&lt;br /&gt;
|Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &lt;br /&gt;
|&#039;&#039;Biopreservation and Biobanking&#039;&#039;,&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;14&#039;&#039;(1), 9–16&lt;br /&gt;
|https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Clinical Research Recession: Training Needs Perception Among Medical Students. &lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;32&#039;&#039;(4), 728–733.&lt;br /&gt;
|https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S.&lt;br /&gt;
|A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.&lt;br /&gt;
|&#039;&#039;International Ophthalmology&#039;&#039;&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(1), 111–118.&lt;br /&gt;
|https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(4), 345–351.&lt;br /&gt;
|https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases.&lt;br /&gt;
|&#039;&#039;Cancer Medicine&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;6&#039;&#039;(7), 1817–1826.&lt;br /&gt;
|https://doi.org/10.1002/cam4.1122&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;39&#039;&#039;(2), 150–152.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000699&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Rashed, W. M.&lt;br /&gt;
|Risk of second malignancies among survivors of pediatric thyroid cancer.&lt;br /&gt;
|&#039;&#039;International Journal of Clinical Oncology&#039;&#039;,&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;23&#039;&#039;(4), 625–633.&lt;br /&gt;
|https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study.&lt;br /&gt;
|&#039;&#039;Endocrine Connections&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;7&#039;&#039;(10), 1040–1048.&lt;br /&gt;
|https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A.&lt;br /&gt;
|Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study.&lt;br /&gt;
|&#039;&#039;International Journal of Neuroscience&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;0&#039;&#039;(0), 1–8.&lt;br /&gt;
|https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Chamdine, O., Elhawary, G. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &lt;br /&gt;
|&#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;&lt;br /&gt;
|2018&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 431–439&lt;br /&gt;
|https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., &amp;amp; Hamoda, H. M.&lt;br /&gt;
|Suicidal death within a year of a cancer diagnosis: A population-based study.&lt;br /&gt;
|&#039;&#039;Cancer&#039;&#039;&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;125&#039;&#039;(6), 972–979&lt;br /&gt;
|https://doi.org/10.1002/cncr.31876&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Reichhart, N., Schöberl, S., Keckeis, S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O.&lt;br /&gt;
|Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &lt;br /&gt;
|&#039;&#039;Scientific Reports&#039;&#039;,&lt;br /&gt;
|2019&lt;br /&gt;
|&#039;&#039;9&#039;&#039;(1), 2257&lt;br /&gt;
|https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Cordes, M., Bucichowski, P., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O.&lt;br /&gt;
|Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells.&lt;br /&gt;
|&#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;May 2019&#039;&#039;, fj.201901202RR&lt;br /&gt;
|https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries.&lt;br /&gt;
|&#039;&#039;Pediatric Hematology and Oncology&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|198-210&lt;br /&gt;
|https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|259, 515–526&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association of Brain Cancer With Risk of Suicide.&lt;br /&gt;
|&#039;&#039;JAMA Network Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;3&#039;&#039;(5), e203862&lt;br /&gt;
|https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients.&lt;br /&gt;
|&#039;&#039;Eye&#039;&#039;.&lt;br /&gt;
|2020&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. &lt;br /&gt;
|Uveal melanoma-associated cancers revisited. &lt;br /&gt;
|&#039;&#039;ESMO Open&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;5&#039;&#039;(6), e000990.&lt;br /&gt;
|https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. &lt;br /&gt;
|Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body.&lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. &lt;br /&gt;
|2020&lt;br /&gt;
|&lt;br /&gt;
|https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. &lt;br /&gt;
|Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study.&lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;, 1–14&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T.&lt;br /&gt;
|Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &lt;br /&gt;
|&#039;&#039;The Lancet Global Health&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;20&#039;&#039;&lt;br /&gt;
|https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hammad, M., Hosny, M., Khalil, E., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Fawzy, M.&lt;br /&gt;
|Pediatric ependymoma: A single-center experience from a developing country.&lt;br /&gt;
|&#039;&#039;Indian Journal of Cancer&#039;&#039;&lt;br /&gt;
|2020&lt;br /&gt;
|&#039;&#039;55&#039;&#039;(1), 382–389&lt;br /&gt;
|https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M.&lt;br /&gt;
|The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &lt;br /&gt;
|&#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;&lt;br /&gt;
|2021&lt;br /&gt;
|260, pages1723–1731 &lt;br /&gt;
|https://doi.org/10.1007/s00417-021-05317-7&lt;br /&gt;
|&lt;br /&gt;
|}&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=56</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=56"/>
		<updated>2022-12-24T00:50:45Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Authors&lt;br /&gt;
!Title&lt;br /&gt;
!Journal&lt;br /&gt;
!Online&lt;br /&gt;
!Volume, Issue, Pages&lt;br /&gt;
!DOI&lt;br /&gt;
!IF&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A.&lt;br /&gt;
|International telepharmacy education: another venue to improve cancer care in the developing world.&lt;br /&gt;
|&#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;18&#039;&#039;(6), 470–474.&lt;br /&gt;
|https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., &#039;&#039;&#039;Samir&#039;&#039;&#039;, A., &amp;amp; Younes, A. A. &lt;br /&gt;
|Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &lt;br /&gt;
|&#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;&lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;11&#039;&#039;(8), 484–490&lt;br /&gt;
|https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Shohdy, K. S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &lt;br /&gt;
|&#039;&#039;Therapeutic Delivery&#039;&#039;&lt;br /&gt;
|2013&lt;br /&gt;
|&#039;&#039;4&#039;&#039;(9), 1197–1209&lt;br /&gt;
|https://doi.org/10.4155/tde.13.75&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Amgad, M., &amp;amp; &#039;&#039;&#039;AlFaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Integrating web 2.0 in clinical research education in a developing country.&lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;29&#039;&#039;(3), 536–540&lt;br /&gt;
|https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A., &amp;amp; Nour, R.&lt;br /&gt;
|What a reference manager can add for a physician in web 2.0 era.&lt;br /&gt;
|&#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;8&#039;&#039;(2), 55&lt;br /&gt;
|https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Orbital tumors in USA: Difference in survival patterns.&lt;br /&gt;
|&#039;&#039;Cancer Epidemiology&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(5), 515–522&lt;br /&gt;
|https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma.&lt;br /&gt;
|&#039;&#039;Fetal and Pediatric Pathology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 176–184.&lt;br /&gt;
|https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney.&lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N.&lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Association between quality of clinical trials and human development index in heart failure using JADAD scale.&lt;br /&gt;
|&#039;&#039;Principles and Practice of Clinical Research&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;1&#039;&#039;(2), 40–46&lt;br /&gt;
|https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El-Nadi, E., Elzomor, H., Labib, R. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M.&lt;br /&gt;
|Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &lt;br /&gt;
|&#039;&#039;Journal of Solid Tumors&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;2&#039;&#039;(5), 94&lt;br /&gt;
|https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S. &lt;br /&gt;
|Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(4), 195–203&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of Orbit: Is it So Fatal?&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(6), 493&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Labib, R. M., Mostafa, M. M., &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S.&lt;br /&gt;
|Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &lt;br /&gt;
|&#039;&#039;Biopreservation and Biobanking&#039;&#039;,&lt;br /&gt;
|2016&lt;br /&gt;
|&#039;&#039;14&#039;&#039;(1), 9–16&lt;br /&gt;
|https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Clinical Research Recession: Training Needs Perception Among Medical Students. &lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;32&#039;&#039;(4), 728–733.&lt;br /&gt;
|https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S.&lt;br /&gt;
|A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt.&lt;br /&gt;
|&#039;&#039;International Ophthalmology&#039;&#039;&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(1), 111–118.&lt;br /&gt;
|https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt.&lt;br /&gt;
|&#039;&#039;Ophthalmic Genetics&#039;&#039;, &lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(4), 345–351.&lt;br /&gt;
|https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. &lt;br /&gt;
|Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases.&lt;br /&gt;
|&#039;&#039;Cancer Medicine&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;6&#039;&#039;(7), 1817–1826.&lt;br /&gt;
|https://doi.org/10.1002/cam4.1122&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;,&lt;br /&gt;
|2017&lt;br /&gt;
|&#039;&#039;39&#039;&#039;(2), 150–152.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000699&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|} &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., Alfaar, A. S., &amp;amp; Rashed, W. M. (2018). Risk of second malignancies among survivors of pediatric thyroid cancer. &#039;&#039;International Journal of Clinical Oncology&#039;&#039;, &#039;&#039;23&#039;&#039;(4), 625–633. https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; Alfaar, A. S. (2018). Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. &#039;&#039;Endocrine Connections&#039;&#039;, &#039;&#039;7&#039;&#039;(10), 1040–1048. https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir Alfaar, A. (2018). Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study. &#039;&#039;International Journal of Neuroscience&#039;&#039;, &#039;&#039;0&#039;&#039;(0), 1–8. https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Chamdine, O., Elhawary, G. A. S., Alfaar, A. S., &amp;amp; Qaddoumi, I. (2018). The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 431–439. https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., Alfaar, A. S., &amp;amp; Hamoda, H. M. (2019). Suicidal death within a year of a cancer diagnosis: A population-based study. &#039;&#039;Cancer&#039;&#039;, &#039;&#039;125&#039;&#039;(6), 972–979. https://doi.org/10.1002/cncr.31876&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Reichhart, N., Schöberl, S., Keckeis, S., Alfaar, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O. (2019). Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &#039;&#039;Scientific Reports&#039;&#039;, &#039;&#039;9&#039;&#039;(1), 2257. https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cordes, M., Bucichowski, P., Alfaar, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O. (2020). Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells. &#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;, &#039;&#039;May 2019&#039;&#039;, fj.201901202RR. https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; Alfaar, A. S. (2020). The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. &#039;&#039;Pediatric Hematology and Oncology&#039;&#039;, 1–13. https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; Alfaar, A. S. (2020). Association of Brain Cancer With Risk of Suicide. &#039;&#039;JAMA Network Open&#039;&#039;, &#039;&#039;3&#039;&#039;(5), e203862. https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; Alfaar, A. S. (2020). Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. &#039;&#039;Eye&#039;&#039;. https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. (2020). Uveal melanoma-associated cancers revisited. &#039;&#039;ESMO Open&#039;&#039;, &#039;&#039;5&#039;&#039;(6), e000990. https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., Alfaar, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. (2020). Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;, 1–14. https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., Alfaar, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T. (2020). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;. https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hammad, M., Hosny, M., Khalil, E., Alfaar, A., &amp;amp; Fawzy, M. (2020). Pediatric ependymoma: A single-center experience from a developing country. &#039;&#039;Indian Journal of Cancer&#039;&#039;, &#039;&#039;55&#039;&#039;(1), 382–389. https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M. (2021). The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;, &#039;&#039;Accepted&#039;&#039;. https://doi.org/10.1007/s00417-021-05317-7&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=55</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=55"/>
		<updated>2022-12-24T00:38:44Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| class=&amp;quot;wikitable sortable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Authors&lt;br /&gt;
!Title&lt;br /&gt;
!Journal&lt;br /&gt;
!Online&lt;br /&gt;
!Volume, Issue, Pages&lt;br /&gt;
!DOI&lt;br /&gt;
!IF&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A.&lt;br /&gt;
|International telepharmacy education: another venue to improve cancer care in the developing world.&lt;br /&gt;
|&#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;18&#039;&#039;(6), 470–474.&lt;br /&gt;
|https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., &#039;&#039;&#039;Samir&#039;&#039;&#039;, A., &amp;amp; Younes, A. A. &lt;br /&gt;
|Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &lt;br /&gt;
|&#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;&lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;11&#039;&#039;(8), 484–490&lt;br /&gt;
|https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Shohdy, K. S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &lt;br /&gt;
|&#039;&#039;Therapeutic Delivery&#039;&#039;&lt;br /&gt;
|2013&lt;br /&gt;
|&#039;&#039;4&#039;&#039;(9), 1197–1209&lt;br /&gt;
|https://doi.org/10.4155/tde.13.75&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Amgad, M., &amp;amp; AlFaar, A. S. &lt;br /&gt;
|Integrating web 2.0 in clinical research education in a developing country.&lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;29&#039;&#039;(3), 536–540&lt;br /&gt;
|https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Alfaar, A., &amp;amp; Nour, R.&lt;br /&gt;
|What a reference manager can add for a physician in web 2.0 era.&lt;br /&gt;
|&#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;8&#039;&#039;(2), 55&lt;br /&gt;
|https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Alfaar, A. S., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Orbital tumors in USA: Difference in survival patterns.&lt;br /&gt;
|&#039;&#039;Cancer Epidemiology&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(5), 515–522&lt;br /&gt;
|https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma.&lt;br /&gt;
|&#039;&#039;Fetal and Pediatric Pathology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 176–184.&lt;br /&gt;
|https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney.&lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N.&lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|Association between quality of clinical trials and human development index in heart failure using JADAD scale.&lt;br /&gt;
|&#039;&#039;Principles and Practice of Clinical Research&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;1&#039;&#039;(2), 40–46&lt;br /&gt;
|https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El-Nadi, E., Elzomor, H., Labib, R. M., Alfaar, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M. (2015). Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &#039;&#039;Journal of Solid Tumors&#039;&#039;, &#039;&#039;2&#039;&#039;(5), 94. https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; Alfaar, A. S. (2015). Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(4), 195–203. https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2016). Childhood Ewing Sarcoma of Orbit: Is it So Fatal? &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;38&#039;&#039;(6), 493. https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Labib, R. M., Mostafa, M. M., Alfaar, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S. (2016). Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &#039;&#039;Biopreservation and Biobanking&#039;&#039;, &#039;&#039;14&#039;&#039;(1), 9–16. https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S. (2017). Clinical Research Recession: Training Needs Perception Among Medical Students. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;32&#039;&#039;(4), 728–733. https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S. (2017). A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. &#039;&#039;International Ophthalmology&#039;&#039;, &#039;&#039;37&#039;&#039;(1), 111–118. https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; Alfaar, A. S. (2017). A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. &#039;&#039;Ophthalmic Genetics&#039;&#039;, &#039;&#039;38&#039;&#039;(4), 345–351. https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. (2017). Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases. &#039;&#039;Cancer Medicine&#039;&#039;, &#039;&#039;6&#039;&#039;(7), 1817–1826. https://doi.org/10.1002/cam4.1122&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; Alfaar, A. S. (2017). Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;39&#039;&#039;(2), 150–152. https://doi.org/10.1097/MPH.0000000000000699 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., Alfaar, A. S., &amp;amp; Rashed, W. M. (2018). Risk of second malignancies among survivors of pediatric thyroid cancer. &#039;&#039;International Journal of Clinical Oncology&#039;&#039;, &#039;&#039;23&#039;&#039;(4), 625–633. https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; Alfaar, A. S. (2018). Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. &#039;&#039;Endocrine Connections&#039;&#039;, &#039;&#039;7&#039;&#039;(10), 1040–1048. https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir Alfaar, A. (2018). Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study. &#039;&#039;International Journal of Neuroscience&#039;&#039;, &#039;&#039;0&#039;&#039;(0), 1–8. https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Chamdine, O., Elhawary, G. A. S., Alfaar, A. S., &amp;amp; Qaddoumi, I. (2018). The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 431–439. https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., Alfaar, A. S., &amp;amp; Hamoda, H. M. (2019). Suicidal death within a year of a cancer diagnosis: A population-based study. &#039;&#039;Cancer&#039;&#039;, &#039;&#039;125&#039;&#039;(6), 972–979. https://doi.org/10.1002/cncr.31876&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Reichhart, N., Schöberl, S., Keckeis, S., Alfaar, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O. (2019). Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &#039;&#039;Scientific Reports&#039;&#039;, &#039;&#039;9&#039;&#039;(1), 2257. https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cordes, M., Bucichowski, P., Alfaar, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O. (2020). Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells. &#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;, &#039;&#039;May 2019&#039;&#039;, fj.201901202RR. https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; Alfaar, A. S. (2020). The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. &#039;&#039;Pediatric Hematology and Oncology&#039;&#039;, 1–13. https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; Alfaar, A. S. (2020). Association of Brain Cancer With Risk of Suicide. &#039;&#039;JAMA Network Open&#039;&#039;, &#039;&#039;3&#039;&#039;(5), e203862. https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; Alfaar, A. S. (2020). Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. &#039;&#039;Eye&#039;&#039;. https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. (2020). Uveal melanoma-associated cancers revisited. &#039;&#039;ESMO Open&#039;&#039;, &#039;&#039;5&#039;&#039;(6), e000990. https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., Alfaar, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. (2020). Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;, 1–14. https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., Alfaar, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T. (2020). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;. https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hammad, M., Hosny, M., Khalil, E., Alfaar, A., &amp;amp; Fawzy, M. (2020). Pediatric ependymoma: A single-center experience from a developing country. &#039;&#039;Indian Journal of Cancer&#039;&#039;, &#039;&#039;55&#039;&#039;(1), 382–389. https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M. (2021). The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;, &#039;&#039;Accepted&#039;&#039;. https://doi.org/10.1007/s00417-021-05317-7&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=54</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=54"/>
		<updated>2022-12-24T00:34:28Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;{| class=&amp;quot;wikitable&amp;quot;&lt;br /&gt;
|+&lt;br /&gt;
!Authors&lt;br /&gt;
!Title&lt;br /&gt;
!Journal&lt;br /&gt;
!Online&lt;br /&gt;
!Volume, Issue, Pages&lt;br /&gt;
!DOI&lt;br /&gt;
!IF&lt;br /&gt;
|-&lt;br /&gt;
|&#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A.&lt;br /&gt;
|International telepharmacy education: another venue to improve cancer care in the developing world.&lt;br /&gt;
|&#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;18&#039;&#039;(6), 470–474.&lt;br /&gt;
|https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., &#039;&#039;&#039;Samir&#039;&#039;&#039;, A., &amp;amp; Younes, A. A. &lt;br /&gt;
|Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &lt;br /&gt;
|&#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;&lt;br /&gt;
|2012&lt;br /&gt;
|&#039;&#039;11&#039;&#039;(8), 484–490&lt;br /&gt;
|https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Shohdy, K. S., &amp;amp; &#039;&#039;&#039;Alfaar&#039;&#039;&#039;, A. S.&lt;br /&gt;
|Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &lt;br /&gt;
|&#039;&#039;Therapeutic Delivery&#039;&#039;&lt;br /&gt;
|2013&lt;br /&gt;
|&#039;&#039;4&#039;&#039;(9), 1197–1209&lt;br /&gt;
|https://doi.org/10.4155/tde.13.75&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Amgad, M., &amp;amp; AlFaar, A. S. &lt;br /&gt;
|Integrating web 2.0 in clinical research education in a developing country.&lt;br /&gt;
|&#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;29&#039;&#039;(3), 536–540&lt;br /&gt;
|https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Alfaar, A., &amp;amp; Nour, R.&lt;br /&gt;
|What a reference manager can add for a physician in web 2.0 era.&lt;br /&gt;
|&#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;8&#039;&#039;(2), 55&lt;br /&gt;
|https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Alfaar, A. S., Bakry, M. S., &amp;amp; Ezzat, S.&lt;br /&gt;
|Orbital tumors in USA: Difference in survival patterns.&lt;br /&gt;
|&#039;&#039;Cancer Epidemiology&#039;&#039;&lt;br /&gt;
|2014&lt;br /&gt;
|&#039;&#039;38&#039;&#039;(5), 515–522&lt;br /&gt;
|https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma.&lt;br /&gt;
|&#039;&#039;Fetal and Pediatric Pathology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;34&#039;&#039;(3), 176–184.&lt;br /&gt;
|https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney.&lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. &lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|Bilateral clear cell sarcoma of the kidney. &lt;br /&gt;
|&#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;,&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;27&#039;&#039;(2), 97–100.&lt;br /&gt;
|https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N.&lt;br /&gt;
|Childhood Ewing Sarcoma of the Orbit.&lt;br /&gt;
|&#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;37&#039;&#039;(6), 433–437.&lt;br /&gt;
|https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; Alfaar, A. S.&lt;br /&gt;
|Association between quality of clinical trials and human development index in heart failure using JADAD scale.&lt;br /&gt;
|&#039;&#039;Principles and Practice of Clinical Research&#039;&#039;&lt;br /&gt;
|2015&lt;br /&gt;
|&#039;&#039;1&#039;&#039;(2), 40–46&lt;br /&gt;
|https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|-&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El-Nadi, E., Elzomor, H., Labib, R. M., Alfaar, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M. (2015). Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &#039;&#039;Journal of Solid Tumors&#039;&#039;, &#039;&#039;2&#039;&#039;(5), 94. https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; Alfaar, A. S. (2015). Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(4), 195–203. https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2016). Childhood Ewing Sarcoma of Orbit: Is it So Fatal? &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;38&#039;&#039;(6), 493. https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Labib, R. M., Mostafa, M. M., Alfaar, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S. (2016). Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &#039;&#039;Biopreservation and Biobanking&#039;&#039;, &#039;&#039;14&#039;&#039;(1), 9–16. https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S. (2017). Clinical Research Recession: Training Needs Perception Among Medical Students. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;32&#039;&#039;(4), 728–733. https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S. (2017). A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. &#039;&#039;International Ophthalmology&#039;&#039;, &#039;&#039;37&#039;&#039;(1), 111–118. https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; Alfaar, A. S. (2017). A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. &#039;&#039;Ophthalmic Genetics&#039;&#039;, &#039;&#039;38&#039;&#039;(4), 345–351. https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. (2017). Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases. &#039;&#039;Cancer Medicine&#039;&#039;, &#039;&#039;6&#039;&#039;(7), 1817–1826. https://doi.org/10.1002/cam4.1122&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; Alfaar, A. S. (2017). Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;39&#039;&#039;(2), 150–152. https://doi.org/10.1097/MPH.0000000000000699 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., Alfaar, A. S., &amp;amp; Rashed, W. M. (2018). Risk of second malignancies among survivors of pediatric thyroid cancer. &#039;&#039;International Journal of Clinical Oncology&#039;&#039;, &#039;&#039;23&#039;&#039;(4), 625–633. https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; Alfaar, A. S. (2018). Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. &#039;&#039;Endocrine Connections&#039;&#039;, &#039;&#039;7&#039;&#039;(10), 1040–1048. https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir Alfaar, A. (2018). Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study. &#039;&#039;International Journal of Neuroscience&#039;&#039;, &#039;&#039;0&#039;&#039;(0), 1–8. https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Chamdine, O., Elhawary, G. A. S., Alfaar, A. S., &amp;amp; Qaddoumi, I. (2018). The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 431–439. https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., Alfaar, A. S., &amp;amp; Hamoda, H. M. (2019). Suicidal death within a year of a cancer diagnosis: A population-based study. &#039;&#039;Cancer&#039;&#039;, &#039;&#039;125&#039;&#039;(6), 972–979. https://doi.org/10.1002/cncr.31876&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Reichhart, N., Schöberl, S., Keckeis, S., Alfaar, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O. (2019). Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &#039;&#039;Scientific Reports&#039;&#039;, &#039;&#039;9&#039;&#039;(1), 2257. https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cordes, M., Bucichowski, P., Alfaar, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O. (2020). Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells. &#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;, &#039;&#039;May 2019&#039;&#039;, fj.201901202RR. https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; Alfaar, A. S. (2020). The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. &#039;&#039;Pediatric Hematology and Oncology&#039;&#039;, 1–13. https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; Alfaar, A. S. (2020). Association of Brain Cancer With Risk of Suicide. &#039;&#039;JAMA Network Open&#039;&#039;, &#039;&#039;3&#039;&#039;(5), e203862. https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; Alfaar, A. S. (2020). Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. &#039;&#039;Eye&#039;&#039;. https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. (2020). Uveal melanoma-associated cancers revisited. &#039;&#039;ESMO Open&#039;&#039;, &#039;&#039;5&#039;&#039;(6), e000990. https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., Alfaar, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. (2020). Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;, 1–14. https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., Alfaar, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T. (2020). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;. https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hammad, M., Hosny, M., Khalil, E., Alfaar, A., &amp;amp; Fawzy, M. (2020). Pediatric ependymoma: A single-center experience from a developing country. &#039;&#039;Indian Journal of Cancer&#039;&#039;, &#039;&#039;55&#039;&#039;(1), 382–389. https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M. (2021). The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;, &#039;&#039;Accepted&#039;&#039;. https://doi.org/10.1007/s00417-021-05317-7&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=52</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=52"/>
		<updated>2021-11-15T15:38:46Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
[[Uveal melanoma]] is the most common adult primary ocular malignancy. Here we study its incidence in USA. Here we present the incidence rates between 2001 and 2018 on a nationwide level. &lt;br /&gt;
&lt;br /&gt;
Here we provide interactive graphs to support the readers of our publication to better understand the data.&lt;br /&gt;
[[File:Uveal Melanoma Diagnosis per State.png|thumb|Uveal Melanoma diagnosis per state 2001-2018]]&lt;br /&gt;
&lt;br /&gt;
==== Age-standardized Incidence rates ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?publish=yes Incidence rates per State]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRate-Ratiosperstate/UMRateRatios?publish=yes Incidence rate-ratios per state in comparison to the national incidence in US]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRateperagegroup/IncidenceperAgeGgroupsexFig?pub Incidence rates per age group]&lt;br /&gt;
&lt;br /&gt;
==== Trends: ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforsexraceorigin/UMTrendsSex-Race-Origin?publish=yes Trend for sex, race and origin]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforStageDiag_Confirmation/UMTrendsStage-Diag?publish=yes Trend for stage, and method of diagnostic confirmation]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Uveal Melanoma]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=ROP_in_Germany&amp;diff=51</id>
		<title>ROP in Germany</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=ROP_in_Germany&amp;diff=51"/>
		<updated>2021-10-29T11:59:19Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Ahmad Alfaar, Melih parlak, Armin Wolf &lt;br /&gt;
&lt;br /&gt;
=== Results: ===&lt;br /&gt;
Our study included 1,326 patients from 778,090 new births (as estimated by the Statistics office) or 795,132 admissions. Males represented 53.32% (N=707) , and females 46.68% (N=619). This represented 17.04 per 10,000 new births in 2019. The incidence was 17.71 in males and 16.34 in females. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The mean time for hospital stay was 79,5 days (SD = 33.7). This duration represented 18.83 times (t-statistic = -379.145, P &amp;lt; 0.0001) the mean duration of stay for neonatal patients (4.2, SD=7.1)&lt;br /&gt;
&lt;br /&gt;
The Patient related comorbidity score was skewed towards multimorbid status; 0-2: 8.57% (N=111 patients), 3: 22.02% (N=287), 4: 21.64% (N=292), 5: 32.13% (N=426) and score 6: 15.84% (N=210).&lt;br /&gt;
&lt;br /&gt;
Most of the patients had Neonatal jaundice associated with preterm delivery (N=1123, 84.69%), Respiratory distress syndrome of newborn (1072, N=80.84%), Respiratory apnea (Respiratory failure of newborn (n= 740, 55.81%), Other apnea of ​​newborn (n=1046, 78.88%). Other major diagnosed comorbidities included Anemia of prematurity (N=947, 71.42%), and Slow feeding of newborn (N= 758, 57.16%).&lt;br /&gt;
&lt;br /&gt;
The incidence of ROP in the patients with birth weights under 500 grams was 18.7% this increased 31.35% in the group with a birth weight of 500-750 grams then declined in the group of birth weight of 750-1000 grams to 11.53%. &lt;br /&gt;
&lt;br /&gt;
90,27% of the patients (N=1,197) were classified as having a main diagnosis of low weight birth; mainly, 500 - 750 Gram (N=337, 25,41%) and  750-1000 Gramm (N= 336, 25,34%). &lt;br /&gt;
[[File:SideDiag.png|thumb|Number of patients with side diagnosis vs those with main diagnosis]]&lt;br /&gt;
[[File:Duration of Stay.png|thumb|Duration of Stay]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Initial Data, Factors, Procedures in Figures:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
* https://public.tableau.com/views/ROPinGermany/PatientsandMorbidity&lt;br /&gt;
* [https://public.tableau.com/views/ROPinGermany/DurationofStay? https://public.tableau.com/views/ROPinGermany/DurationofStay]&lt;br /&gt;
* [https://public.tableau.com/views/ROPinGermany/FactorsandProcedures?:language=en-GB&amp;amp;publish=yes&amp;amp;:display_count=n&amp;amp;:origin=viz_share_link https://public.tableau.com/views/ROPinGermany/FactorsandProcedures]&lt;br /&gt;
* https://public.tableau.com/views/ROPinGermany/FactorsandProcedures-Summarized&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
Most of the patients were exposed to light therapy for Hyperbilirubinemia (N=1136, 85.67%)and received surfactant (N=951,71.72%). 48 patients( 3.62%) received intraocular injections; 28 (2.11%) received Ranibizumab, 26 received laser photo coagulation. &lt;br /&gt;
&lt;br /&gt;
The majority of the patients were admitted to large public hospitals with 1000 beds or more (N=566, 42.68%)&lt;br /&gt;
&lt;br /&gt;
====  Death: ====&lt;br /&gt;
A total of eight patients died after their diagnosis within the hospital; four males and two females. This represented a death rate of 60.33 per 10,000, a higher rate than total neonatal death rate (24.2 per 10,000). The mean duration of stay of the patients was 110.9 (SD=29.3, HK =79,11 % ). All of the patients had Respiratory distress syndrome and seven of them were diagnosed with Bronchopulmonary dysplasia originating in the perinatal period that required surfactant. Moreover, seven have had neonatal jaundice and were exposed to light therapy.&lt;br /&gt;
&lt;br /&gt;
Further 3 patients died after 28 days.&lt;br /&gt;
&lt;br /&gt;
The death rate was 65.13% in the group of patients with birth weight less than 500 gm, and declined to 23.16% in the group of birth weight of 500-750 gm and 6.12% in the group of 750-1000 gm.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Made in Ulm&lt;br /&gt;
&lt;br /&gt;
[[File:Uniklinik-ulm-logo.png|frameless]]&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=ROP_in_Germany&amp;diff=50</id>
		<title>ROP in Germany</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=ROP_in_Germany&amp;diff=50"/>
		<updated>2021-10-29T09:19:36Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Ahmad Alfaar, Melih parlak, Armin Wolf &lt;br /&gt;
&lt;br /&gt;
=== Results: ===&lt;br /&gt;
Our study included 1,326 patients from 778,090 new births (as estimated by the Statistics office) or 795,132 admissions. Males represented 53.32% (N=707) , and females 46.68% (N=619). This represented 17.04 per 10,000 new births in 2019. The incidence was 17.71 in males and 16.34 in females. &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
The mean time for hospital stay was 79,5 days (SD = 33.7). This duration represented 18.83 times (t-statistic = -379.145, P &amp;lt; 0.0001) the mean duration of stay for neonatal patients (4.2, SD=7.1)&lt;br /&gt;
&lt;br /&gt;
The Patient related comorbidity score was skewed towards multimorbid status; 0-2: 8.57% (N=111 patients), 3: 22.02% (N=287), 4: 21.64% (N=292), 5: 32.13% (N=426) and score 6: 15.84% (N=210).&lt;br /&gt;
&lt;br /&gt;
Most of the patients had Neonatal jaundice associated with preterm delivery (N=1123, 84.69%), Respiratory distress syndrome of newborn (1072, N=80.84%), Respiratory apnea (Respiratory failure of newborn (n= 740, 55.81%), Other apnea of ​​newborn (n=1046, 78.88%). Other major diagnosed comorbidities included Anemia of prematurity (N=947, 71.42%), and Slow feeding of newborn (N= 758, 57.16%).&lt;br /&gt;
&lt;br /&gt;
The incidence of ROP in the patients with birth weights under 500 grams was 18.7% this increased 31.35% in the group with a birth weight of 500-750 grams then declined in the group of birth weight of 750-1000 grams to 11.53%. &lt;br /&gt;
&lt;br /&gt;
90,27% of the patients (N=1,197) were classified as having a main diagnosis of low weight birth; mainly, 500 - 750 Gram (N=337, 25,41%) and  750-1000 Gramm (N= 336, 25,34%). &lt;br /&gt;
[[File:SideDiag.png|thumb|Number of patients with side diagnosis vs those with main diagnosis]]&lt;br /&gt;
[[File:Duration of Stay.png|thumb|Duration of Stay]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&#039;&#039;&#039;Initial Data, Factors, Procedures in Figures:&#039;&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
https://public.tableau.com/app/profile/ahmed.alfaar/viz/ROPinGermany/DurationofStay&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
Most of the patients were exposed to light therapy for Hyperbilirubinemia (N=1136, 85.67%)and received surfactant (N=951,71.72%). 48 patients( 3.62%) received intraocular injections; 28 (2.11%) received Ranibizumab, 26 received laser photo coagulation. &lt;br /&gt;
&lt;br /&gt;
The majority of the patients were admitted to large public hospitals with 1000 beds or more (N=566, 42.68%)&lt;br /&gt;
&lt;br /&gt;
====  Death: ====&lt;br /&gt;
A total of eight patients died after their diagnosis within the hospital; four males and two females. This represented a death rate of 60.33 per 10,000, a higher rate than total neonatal death rate (24.2 per 10,000). The mean duration of stay of the patients was 110.9 (SD=29.3, HK =79,11 % ). All of the patients had Respiratory distress syndrome and seven of them were diagnosed with Bronchopulmonary dysplasia originating in the perinatal period that required surfactant. Moreover, seven have had neonatal jaundice and were exposed to light therapy.&lt;br /&gt;
&lt;br /&gt;
Further 3 patients died after 28 days.&lt;br /&gt;
&lt;br /&gt;
The death rate was 65.13% in the group of patients with birth weight less than 500 gm, and declined to 23.16% in the group of birth weight of 500-750 gm and 6.12% in the group of 750-1000 gm.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Made in Ulm&lt;br /&gt;
&lt;br /&gt;
[[File:Uniklinik-ulm-logo.png|frameless]]&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=49</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=49"/>
		<updated>2021-10-16T22:17:09Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
[[Uveal melanoma]] is the most common adult primary ocular malignancy. Here we study its incidence in USA. Here we present the incidence rates between 2001 and 2018 on a nationwide level. &lt;br /&gt;
&lt;br /&gt;
Here we provide interactive graphs to support the readers of our publication to better understand the data.&lt;br /&gt;
[[File:Uveal Melanoma Diagnosis per State.png|thumb|Uveal Melanoma diagnosis per state 2001-2018]]&lt;br /&gt;
&lt;br /&gt;
==== Age-standardized Incidence rates ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?publish=yes Incidence rates per State]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRate-Ratiosperstate/UMRateRatios?publish=yes Incidence rate-ratios per state in comparison to the national incidence in US]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRateperagegroup/IncidenceperAgeGgroupsexFig?pub Incidence rates per age group]&lt;br /&gt;
&lt;br /&gt;
==== Trends: ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforsexraceorigin/UMTrendsSex-Race-Origin?publish=yes Trend for sex, race and origin]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforStageDiag_Confirmation/UMTrendsStage-Diag?publish=yes Trend for stage, and method of diagnostic confirmation]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Uveal Melanoma]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
Uveal Melanoma is the most common primary ocular malignancy in adults.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=48</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=48"/>
		<updated>2021-10-16T22:14:55Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&lt;br /&gt;
[[Uveal melanoma]] is the most common adult primary ocular malignancy. Here we study its incidence in USA. Here we present the incidence rates between 2001 and 2018 on a nationwide level.&lt;br /&gt;
[[File:Uveal Melanoma Diagnosis per State.png|thumb|Uveal Melanoma diagnosis per state 2001-2018]]&lt;br /&gt;
&lt;br /&gt;
==== Age-standardized Incidence rates ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?publish=yes Incidence rates per State]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRate-Ratiosperstate/UMRateRatios?publish=yes Incidence rate-ratios per state in comparison to the national incidence in US]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRateperagegroup/IncidenceperAgeGgroupsexFig?pub Incidence rates per age group]&lt;br /&gt;
&lt;br /&gt;
==== Trends: ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforsexraceorigin/UMTrendsSex-Race-Origin?publish=yes Trend for sex, race and origin]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforStageDiag_Confirmation/UMTrendsStage-Diag?publish=yes Trend for stage, and method of diagnostic confirmation]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Uveal Melanoma]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
Uveal Melanoma is the most common primary ocular malignancy in adults.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=File:Uveal_Melanoma_Diagnosis_per_State.png&amp;diff=47</id>
		<title>File:Uveal Melanoma Diagnosis per State.png</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=File:Uveal_Melanoma_Diagnosis_per_State.png&amp;diff=47"/>
		<updated>2021-10-16T22:13:31Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;between 2001-2018&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=46</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=46"/>
		<updated>2021-10-16T11:45:32Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Uveal melanoma]] is the most common adult primary ocular malignancy. Here we study its incidence in USA. Here we present the incidence rates between 2001 and 2018 on a nationwide level.&lt;br /&gt;
&lt;br /&gt;
==== Age-standardized Incidence rates ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?publish=yes Incidence rates per State]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRate-Ratiosperstate/UMRateRatios?publish=yes Incidence rate-ratios per state in comparison to the national incidence in US]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRateperagegroup/IncidenceperAgeGgroupsexFig?pub Incidence rates per age group]&lt;br /&gt;
&lt;br /&gt;
==== Trends: ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforsexraceorigin/UMTrendsSex-Race-Origin?publish=yes Trend for sex, race and origin]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforStageDiag_Confirmation/UMTrendsStage-Diag?publish=yes Trend for stage, and method of diagnostic confirmation]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Uveal Melanoma]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
Uveal Melanoma is the most common primary ocular malignancy in adults.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Category:%27%27%27%27%27Uveal_Melanoma%27%27%27%27%27&amp;diff=45</id>
		<title>Category:&#039;&#039;&#039;&#039;&#039;Uveal Melanoma&#039;&#039;&#039;&#039;&#039;</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Category:%27%27%27%27%27Uveal_Melanoma%27%27%27%27%27&amp;diff=45"/>
		<updated>2021-10-15T21:29:44Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: Blanked the page&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Category:Uveal_Melanoma&amp;diff=44</id>
		<title>Category:Uveal Melanoma</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Category:Uveal_Melanoma&amp;diff=44"/>
		<updated>2021-10-15T12:26:54Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: Created page with &amp;quot;Uveal melanoma is the most common adult primary ocular malignancy. Here we study its incidence in USA.&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Uveal melanoma is the most common adult primary ocular malignancy. Here we study its incidence in USA.&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=43</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=43"/>
		<updated>2021-10-15T12:26:31Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Uveal melanoma]] is the most common adult primary ocular malignancy. Here we study its incidence in USA.&lt;br /&gt;
&lt;br /&gt;
==== Age-standardized Incidence rates ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?publish=yes Incidence rates per State]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRate-Ratiosperstate/UMRateRatios?publish=yes Incidence rate-ratios per state in comparison to the national incidence in US]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRateperagegroup/IncidenceperAgeGgroupsexFig?pub Incidence rates per age group]&lt;br /&gt;
&lt;br /&gt;
==== Trends: ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforsexraceorigin/UMTrendsSex-Race-Origin?publish=yes Trend for sex, race and origin]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforStageDiag_Confirmation/UMTrendsStage-Diag?publish=yes Trend for stage, and method of diagnostic confirmation]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:Uveal Melanoma]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
Uveal Melanoma is the most common primary ocular malignancy in adults.&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Category:Ocular_Oncology&amp;diff=42</id>
		<title>Category:Ocular Oncology</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Category:Ocular_Oncology&amp;diff=42"/>
		<updated>2021-10-15T12:25:41Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: Created page with &amp;quot;A field of studying eye tumors&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;A field of studying eye tumors&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_melanoma&amp;diff=41</id>
		<title>Uveal melanoma</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_melanoma&amp;diff=41"/>
		<updated>2021-10-15T12:25:03Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Uveal Melanoma is the most common primary ocular malignancy in adults.&lt;br /&gt;
[[Category:Ocular Oncology]]&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Category:%27%27%27%27%27Uveal_Melanoma%27%27%27%27%27&amp;diff=40</id>
		<title>Category:&#039;&#039;&#039;&#039;&#039;Uveal Melanoma&#039;&#039;&#039;&#039;&#039;</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Category:%27%27%27%27%27Uveal_Melanoma%27%27%27%27%27&amp;diff=40"/>
		<updated>2021-10-15T12:22:41Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: Created page with &amp;quot;Uveal Melanoma is the most common primary ocular malignancy in adults.&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Uveal Melanoma is the most common primary ocular malignancy in adults.&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=39</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=39"/>
		<updated>2021-10-15T12:21:27Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;[[Uveal melanoma]] is the most common adult primary ocular malignancy. Here we study its incidence in USA.&lt;br /&gt;
&lt;br /&gt;
==== Age-standardized Incidence rates ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?publish=yes Incidence rates per State]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRate-Ratiosperstate/UMRateRatios?publish=yes Incidence rate-ratios per state in comparison to the national incidence in US]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRateperagegroup/IncidenceperAgeGgroupsexFig?pub Incidence rates per age group]&lt;br /&gt;
&lt;br /&gt;
==== Trends: ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforsexraceorigin/UMTrendsSex-Race-Origin?publish=yes Trend for sex, race and origin]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforStageDiag_Confirmation/UMTrendsStage-Diag?publish=yes Trend for stage, and method of diagnostic confirmation]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
[[Category:&#039;&#039;&#039;&#039;&#039;Uveal Melanoma&#039;&#039;&#039;&#039;&#039;]]&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_melanoma&amp;diff=38</id>
		<title>Uveal melanoma</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_melanoma&amp;diff=38"/>
		<updated>2021-10-15T08:05:56Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: Created page with &amp;quot;Uveal Melanoma is the most common primary ocular malignancy in adults.&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Uveal Melanoma is the most common primary ocular malignancy in adults.&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=37</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=37"/>
		<updated>2021-10-10T15:28:38Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Alfaar, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A. (2012). International telepharmacy education: another venue to improve cancer care in the developing world. &#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &#039;&#039;18&#039;&#039;(6), 470–474. https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., Samir, A., &amp;amp; Younes, A. A. (2012). Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;, &#039;&#039;11&#039;&#039;(8), 484–490. https://doi.org/10.1007/s10330-012-1011-z &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Amgad, M., &amp;amp; AlFaar, A. S. (2014). Integrating web 2.0 in clinical research education in a developing country. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;29&#039;&#039;(3), 536–540. https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A., &amp;amp; Nour, R. (2014). What a reference manager can add for a physician in web 2.0 era. &#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &#039;&#039;8&#039;&#039;(2), 55. https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hassan, W. M., Alfaar, A. S., Bakry, M. S., &amp;amp; Ezzat, S. (2014). Orbital tumors in USA: Difference in survival patterns. &#039;&#039;Cancer Epidemiology&#039;&#039;, &#039;&#039;38&#039;&#039;(5), 515–522. https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S. (2015). Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. &#039;&#039;Fetal and Pediatric Pathology&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S. (2015). Bilateral clear cell sarcoma of the kidney. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(2), 97–100. https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S. (2015). Bilateral clear cell sarcoma of the kidney. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(2), 97–100. https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; Alfaar, A. S. (2015). Association between quality of clinical trials and human development index in heart failure using JADAD scale. &#039;&#039;Principles and Practice of Clinical Research&#039;&#039;, &#039;&#039;1&#039;&#039;(2), 40–46. https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El-Nadi, E., Elzomor, H., Labib, R. M., Alfaar, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M. (2015). Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &#039;&#039;Journal of Solid Tumors&#039;&#039;, &#039;&#039;2&#039;&#039;(5), 94. https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; Alfaar, A. S. (2015). Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(4), 195–203. https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2016). Childhood Ewing Sarcoma of Orbit: Is it So Fatal? &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;38&#039;&#039;(6), 493. https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Labib, R. M., Mostafa, M. M., Alfaar, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S. (2016). Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &#039;&#039;Biopreservation and Biobanking&#039;&#039;, &#039;&#039;14&#039;&#039;(1), 9–16. https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S. (2017). Clinical Research Recession: Training Needs Perception Among Medical Students. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;32&#039;&#039;(4), 728–733. https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S. (2017). A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. &#039;&#039;International Ophthalmology&#039;&#039;, &#039;&#039;37&#039;&#039;(1), 111–118. https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; Alfaar, A. S. (2017). A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. &#039;&#039;Ophthalmic Genetics&#039;&#039;, &#039;&#039;38&#039;&#039;(4), 345–351. https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. (2017). Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases. &#039;&#039;Cancer Medicine&#039;&#039;, &#039;&#039;6&#039;&#039;(7), 1817–1826. https://doi.org/10.1002/cam4.1122&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; Alfaar, A. S. (2017). Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;39&#039;&#039;(2), 150–152. https://doi.org/10.1097/MPH.0000000000000699 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., Alfaar, A. S., &amp;amp; Rashed, W. M. (2018). Risk of second malignancies among survivors of pediatric thyroid cancer. &#039;&#039;International Journal of Clinical Oncology&#039;&#039;, &#039;&#039;23&#039;&#039;(4), 625–633. https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; Alfaar, A. S. (2018). Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. &#039;&#039;Endocrine Connections&#039;&#039;, &#039;&#039;7&#039;&#039;(10), 1040–1048. https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir Alfaar, A. (2018). Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study. &#039;&#039;International Journal of Neuroscience&#039;&#039;, &#039;&#039;0&#039;&#039;(0), 1–8. https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Chamdine, O., Elhawary, G. A. S., Alfaar, A. S., &amp;amp; Qaddoumi, I. (2018). The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 431–439. https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., Alfaar, A. S., &amp;amp; Hamoda, H. M. (2019). Suicidal death within a year of a cancer diagnosis: A population-based study. &#039;&#039;Cancer&#039;&#039;, &#039;&#039;125&#039;&#039;(6), 972–979. https://doi.org/10.1002/cncr.31876&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Reichhart, N., Schöberl, S., Keckeis, S., Alfaar, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O. (2019). Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &#039;&#039;Scientific Reports&#039;&#039;, &#039;&#039;9&#039;&#039;(1), 2257. https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cordes, M., Bucichowski, P., Alfaar, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O. (2020). Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells. &#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;, &#039;&#039;May 2019&#039;&#039;, fj.201901202RR. https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; Alfaar, A. S. (2020). The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. &#039;&#039;Pediatric Hematology and Oncology&#039;&#039;, 1–13. https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; Alfaar, A. S. (2020). Association of Brain Cancer With Risk of Suicide. &#039;&#039;JAMA Network Open&#039;&#039;, &#039;&#039;3&#039;&#039;(5), e203862. https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; Alfaar, A. S. (2020). Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. &#039;&#039;Eye&#039;&#039;. https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. (2020). Uveal melanoma-associated cancers revisited. &#039;&#039;ESMO Open&#039;&#039;, &#039;&#039;5&#039;&#039;(6), e000990. https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., Alfaar, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. (2020). Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;, 1–14. https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., Alfaar, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T. (2020). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;. https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hammad, M., Hosny, M., Khalil, E., Alfaar, A., &amp;amp; Fawzy, M. (2020). Pediatric ependymoma: A single-center experience from a developing country. &#039;&#039;Indian Journal of Cancer&#039;&#039;, &#039;&#039;55&#039;&#039;(1), 382–389. https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M. (2021). The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;, &#039;&#039;Accepted&#039;&#039;. https://doi.org/10.1007/s00417-021-05317-7&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=36</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=36"/>
		<updated>2021-10-10T15:24:42Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Alfaar, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A. (2012). International telepharmacy education: another venue to improve cancer care in the developing world. &#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &#039;&#039;18&#039;&#039;(6), 470–474. https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., Samir, A., &amp;amp; Younes, A. A. (2012). Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;, &#039;&#039;11&#039;&#039;(8), 484–490. https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
&lt;br /&gt;
Amgad, M., &amp;amp; AlFaar, A. S. (2014). Integrating web 2.0 in clinical research education in a developing country. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;29&#039;&#039;(3), 536–540. https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
Alfaar, A., &amp;amp; Nour, R. (2014). What a reference manager can add for a physician in web 2.0 era. &#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &#039;&#039;8&#039;&#039;(2), 55. https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
Alfaar, A., &amp;amp; Nour, R. (2014). What a reference manager can add for a physician in web 2.0 era. &#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &#039;&#039;8&#039;&#039;(2), 55. https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A., &amp;amp; Nour, R. (2014). What a reference manager can add for a physician in web 2.0 era. &#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &#039;&#039;8&#039;&#039;(2), 55. https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hassan, W. M., Alfaar, A. S., Bakry, M. S., &amp;amp; Ezzat, S. (2014). Orbital tumors in USA: Difference in survival patterns. &#039;&#039;Cancer Epidemiology&#039;&#039;, &#039;&#039;38&#039;&#039;(5), 515–522. https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S. (2015). Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. &#039;&#039;Fetal and Pediatric Pathology&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S. (2015). Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. &#039;&#039;Fetal and Pediatric Pathology&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
&lt;br /&gt;
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S. (2015). Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. &#039;&#039;Fetal and Pediatric Pathology&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S. (2015). Bilateral clear cell sarcoma of the kidney. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(2), 97–100. https://doi.org/10.1016/j.jnci.2015.03.002Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S. (2015). Bilateral clear cell sarcoma of the kidney. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(2), 97–100. https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; Alfaar, A. S. (2015). Association between quality of clinical trials and human development index in heart failure using JADAD scale. &#039;&#039;Principles and Practice of Clinical Research&#039;&#039;, &#039;&#039;1&#039;&#039;(2), 40–46. https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El-Nadi, E., Elzomor, H., Labib, R. M., Alfaar, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M. (2015). Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &#039;&#039;Journal of Solid Tumors&#039;&#039;, &#039;&#039;2&#039;&#039;(5), 94. https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; Alfaar, A. S. (2015). Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(4), 195–203. https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2016). Childhood Ewing Sarcoma of Orbit: Is it So Fatal? &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;38&#039;&#039;(6), 493. https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Labib, R. M., Mostafa, M. M., Alfaar, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S. (2016). Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &#039;&#039;Biopreservation and Biobanking&#039;&#039;, &#039;&#039;14&#039;&#039;(1), 9–16. https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S. (2017). Clinical Research Recession: Training Needs Perception Among Medical Students. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;32&#039;&#039;(4), 728–733. https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S. (2017). A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. &#039;&#039;International Ophthalmology&#039;&#039;, &#039;&#039;37&#039;&#039;(1), 111–118. https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; Alfaar, A. S. (2017). A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. &#039;&#039;Ophthalmic Genetics&#039;&#039;, &#039;&#039;38&#039;&#039;(4), 345–351. https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. (2017). Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases. &#039;&#039;Cancer Medicine&#039;&#039;, &#039;&#039;6&#039;&#039;(7), 1817–1826. https://doi.org/10.1002/cam4.1122&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; Alfaar, A. S. (2017). Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;39&#039;&#039;(2), 150–152. https://doi.org/10.1097/MPH.0000000000000699 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., Alfaar, A. S., &amp;amp; Rashed, W. M. (2018). Risk of second malignancies among survivors of pediatric thyroid cancer. &#039;&#039;International Journal of Clinical Oncology&#039;&#039;, &#039;&#039;23&#039;&#039;(4), 625–633. https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; Alfaar, A. S. (2018). Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. &#039;&#039;Endocrine Connections&#039;&#039;, &#039;&#039;7&#039;&#039;(10), 1040–1048. https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir Alfaar, A. (2018). Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study. &#039;&#039;International Journal of Neuroscience&#039;&#039;, &#039;&#039;0&#039;&#039;(0), 1–8. https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Chamdine, O., Elhawary, G. A. S., Alfaar, A. S., &amp;amp; Qaddoumi, I. (2018). The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 431–439. https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., Alfaar, A. S., &amp;amp; Hamoda, H. M. (2019). Suicidal death within a year of a cancer diagnosis: A population-based study. &#039;&#039;Cancer&#039;&#039;, &#039;&#039;125&#039;&#039;(6), 972–979. https://doi.org/10.1002/cncr.31876&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Reichhart, N., Schöberl, S., Keckeis, S., Alfaar, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O. (2019). Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &#039;&#039;Scientific Reports&#039;&#039;, &#039;&#039;9&#039;&#039;(1), 2257. https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cordes, M., Bucichowski, P., Alfaar, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O. (2020). Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells. &#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;, &#039;&#039;May 2019&#039;&#039;, fj.201901202RR. https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; Alfaar, A. S. (2020). The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. &#039;&#039;Pediatric Hematology and Oncology&#039;&#039;, 1–13. https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; Alfaar, A. S. (2020). Association of Brain Cancer With Risk of Suicide. &#039;&#039;JAMA Network Open&#039;&#039;, &#039;&#039;3&#039;&#039;(5), e203862. https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; Alfaar, A. S. (2020). Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. &#039;&#039;Eye&#039;&#039;. https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. (2020). Uveal melanoma-associated cancers revisited. &#039;&#039;ESMO Open&#039;&#039;, &#039;&#039;5&#039;&#039;(6), e000990. https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., Alfaar, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. (2020). Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;, 1–14. https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., Alfaar, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T. (2020). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;. https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hammad, M., Hosny, M., Khalil, E., Alfaar, A., &amp;amp; Fawzy, M. (2020). Pediatric ependymoma: A single-center experience from a developing country. &#039;&#039;Indian Journal of Cancer&#039;&#039;, &#039;&#039;55&#039;&#039;(1), 382–389. https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M. (2021). The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;, &#039;&#039;Accepted&#039;&#039;. https://doi.org/10.1007/s00417-021-05317-7&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=35</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=35"/>
		<updated>2021-10-10T15:24:03Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Alfaar, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A. (2012). International telepharmacy education: another venue to improve cancer care in the developing world. &#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &#039;&#039;18&#039;&#039;(6), 470–474. https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., Samir, A., &amp;amp; Younes, A. A. (2012). Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;, &#039;&#039;11&#039;&#039;(8), 484–490. https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
&lt;br /&gt;
Amgad, M., &amp;amp; AlFaar, A. S. (2014). Integrating web 2.0 in clinical research education in a developing country. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;29&#039;&#039;(3), 536–540. https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
Alfaar, A., &amp;amp; Nour, R. (2014). What a reference manager can add for a physician in web 2.0 era. &#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &#039;&#039;8&#039;&#039;(2), 55. https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
Alfaar, A., &amp;amp; Nour, R. (2014). What a reference manager can add for a physician in web 2.0 era. &#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &#039;&#039;8&#039;&#039;(2), 55. https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
&lt;br /&gt;
Alfaar, A., &amp;amp; Nour, R. (2014). What a reference manager can add for a physician in web 2.0 era. &#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &#039;&#039;8&#039;&#039;(2), 55. https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
&lt;br /&gt;
Hassan, W. M., Alfaar, A. S., Bakry, M. S., &amp;amp; Ezzat, S. (2014). Orbital tumors in USA: Difference in survival patterns. &#039;&#039;Cancer Epidemiology&#039;&#039;, &#039;&#039;38&#039;&#039;(5), 515–522. https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S. (2015). Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. &#039;&#039;Fetal and Pediatric Pathology&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S. (2015). Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. &#039;&#039;Fetal and Pediatric Pathology&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
&lt;br /&gt;
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S. (2015). Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. &#039;&#039;Fetal and Pediatric Pathology&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S. (2015). Bilateral clear cell sarcoma of the kidney. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(2), 97–100. https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
&lt;br /&gt;
Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; Alfaar, A. S. (2015). Association between quality of clinical trials and human development index in heart failure using JADAD scale. &#039;&#039;Principles and Practice of Clinical Research&#039;&#039;, &#039;&#039;1&#039;&#039;(2), 40–46. https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El-Nadi, E., Elzomor, H., Labib, R. M., Alfaar, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M. (2015). Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &#039;&#039;Journal of Solid Tumors&#039;&#039;, &#039;&#039;2&#039;&#039;(5), 94. https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; Alfaar, A. S. (2015). Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(4), 195–203. https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2016). Childhood Ewing Sarcoma of Orbit: Is it So Fatal? &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;38&#039;&#039;(6), 493. https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Labib, R. M., Mostafa, M. M., Alfaar, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S. (2016). Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &#039;&#039;Biopreservation and Biobanking&#039;&#039;, &#039;&#039;14&#039;&#039;(1), 9–16. https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S. (2017). Clinical Research Recession: Training Needs Perception Among Medical Students. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;32&#039;&#039;(4), 728–733. https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S. (2017). A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. &#039;&#039;International Ophthalmology&#039;&#039;, &#039;&#039;37&#039;&#039;(1), 111–118. https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; Alfaar, A. S. (2017). A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. &#039;&#039;Ophthalmic Genetics&#039;&#039;, &#039;&#039;38&#039;&#039;(4), 345–351. https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. (2017). Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases. &#039;&#039;Cancer Medicine&#039;&#039;, &#039;&#039;6&#039;&#039;(7), 1817–1826. https://doi.org/10.1002/cam4.1122&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; Alfaar, A. S. (2017). Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;39&#039;&#039;(2), 150–152. https://doi.org/10.1097/MPH.0000000000000699 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., Alfaar, A. S., &amp;amp; Rashed, W. M. (2018). Risk of second malignancies among survivors of pediatric thyroid cancer. &#039;&#039;International Journal of Clinical Oncology&#039;&#039;, &#039;&#039;23&#039;&#039;(4), 625–633. https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; Alfaar, A. S. (2018). Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. &#039;&#039;Endocrine Connections&#039;&#039;, &#039;&#039;7&#039;&#039;(10), 1040–1048. https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir Alfaar, A. (2018). Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study. &#039;&#039;International Journal of Neuroscience&#039;&#039;, &#039;&#039;0&#039;&#039;(0), 1–8. https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Chamdine, O., Elhawary, G. A. S., Alfaar, A. S., &amp;amp; Qaddoumi, I. (2018). The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 431–439. https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., Alfaar, A. S., &amp;amp; Hamoda, H. M. (2019). Suicidal death within a year of a cancer diagnosis: A population-based study. &#039;&#039;Cancer&#039;&#039;, &#039;&#039;125&#039;&#039;(6), 972–979. https://doi.org/10.1002/cncr.31876&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Reichhart, N., Schöberl, S., Keckeis, S., Alfaar, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O. (2019). Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &#039;&#039;Scientific Reports&#039;&#039;, &#039;&#039;9&#039;&#039;(1), 2257. https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cordes, M., Bucichowski, P., Alfaar, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O. (2020). Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells. &#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;, &#039;&#039;May 2019&#039;&#039;, fj.201901202RR. https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; Alfaar, A. S. (2020). The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. &#039;&#039;Pediatric Hematology and Oncology&#039;&#039;, 1–13. https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; Alfaar, A. S. (2020). Association of Brain Cancer With Risk of Suicide. &#039;&#039;JAMA Network Open&#039;&#039;, &#039;&#039;3&#039;&#039;(5), e203862. https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; Alfaar, A. S. (2020). Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. &#039;&#039;Eye&#039;&#039;. https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. (2020). Uveal melanoma-associated cancers revisited. &#039;&#039;ESMO Open&#039;&#039;, &#039;&#039;5&#039;&#039;(6), e000990. https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., Alfaar, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. (2020). Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;, 1–14. https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., Alfaar, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T. (2020). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;. https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hammad, M., Hosny, M., Khalil, E., Alfaar, A., &amp;amp; Fawzy, M. (2020). Pediatric ependymoma: A single-center experience from a developing country. &#039;&#039;Indian Journal of Cancer&#039;&#039;, &#039;&#039;55&#039;&#039;(1), 382–389. https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M. (2021). The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;, &#039;&#039;Accepted&#039;&#039;. https://doi.org/10.1007/s00417-021-05317-7&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Publications&amp;diff=34</id>
		<title>Publications</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Publications&amp;diff=34"/>
		<updated>2021-10-10T15:23:31Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;Alfaar, A. S., Kamal, S., Abouelnaga, S., Greene, W. L., Quintana, Y., Ribeiro, R. C., &amp;amp; Qaddoumi, I. A. (2012). International telepharmacy education: another venue to improve cancer care in the developing world. &#039;&#039;Telemedicine Journal and E-Health : The Official Journal of the American Telemedicine Association&#039;&#039;, &#039;&#039;18&#039;&#039;(6), 470–474. https://doi.org/10.1089/tmj.2011.0182&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Meselhy, G. T., Sallam, K. R., Elshafiey, M. M., Refaat, A., Samir, A., &amp;amp; Younes, A. A. (2012). Sonographic guidance for tunneled central venous catheters insertion in pediatric oncologic patients: guided punctures and guide wire localization. &#039;&#039;The Chinese-German Journal of Clinical Oncology&#039;&#039;, &#039;&#039;11&#039;&#039;(8), 484–490. https://doi.org/10.1007/s10330-012-1011-z&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
&lt;br /&gt;
Shohdy, K. S., &amp;amp; Alfaar, A. S. (2013). Nanoparticles targeting mechanisms in cancer therapy: current limitations and emerging solutions. &#039;&#039;Therapeutic Delivery&#039;&#039;, &#039;&#039;4&#039;&#039;(9), 1197–1209. https://doi.org/10.4155/tde.13.75&lt;br /&gt;
&lt;br /&gt;
Amgad, M., &amp;amp; AlFaar, A. S. (2014). Integrating web 2.0 in clinical research education in a developing country. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;29&#039;&#039;(3), 536–540. https://doi.org/10.1007/s13187-013-0595-5&lt;br /&gt;
Alfaar, A., &amp;amp; Nour, R. (2014). What a reference manager can add for a physician in web 2.0 era. &#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &#039;&#039;8&#039;&#039;(2), 55. https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
&lt;br /&gt;
Alfaar, A., &amp;amp; Nour, R. (2014). What a reference manager can add for a physician in web 2.0 era. &#039;&#039;The Egyptian Journal of Cardiothoracic Anesthesia&#039;&#039;, &#039;&#039;8&#039;&#039;(2), 55. https://doi.org/10.4103/1687-9090.143253&lt;br /&gt;
&lt;br /&gt;
Hassan, W. M., Alfaar, A. S., Bakry, M. S., &amp;amp; Ezzat, S. (2014). Orbital tumors in USA: Difference in survival patterns. &#039;&#039;Cancer Epidemiology&#039;&#039;, &#039;&#039;38&#039;&#039;(5), 515–522. https://doi.org/10.1016/j.canep.2014.07.001&lt;br /&gt;
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S. (2015). Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. &#039;&#039;Fetal and Pediatric Pathology&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
&lt;br /&gt;
Taha, H., Amer, H. Z., El-Zomor, H., Alieldin, A., Nour, R., Konsowa, R., Zekri, W., el Nadi, E., &amp;amp; Alfaar, A. S. (2015). Phthisis Bulbi: Clinical and Pathologic Findings in Retinoblastoma. &#039;&#039;Fetal and Pediatric Pathology&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 176–184. https://doi.org/10.3109/15513815.2015.1014951&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Yehia, D., Elshafie, M. M., Zaghloul, M. S., El-Kinaai, N., Taha, H., Refaat, A., Younes, A. A., &amp;amp; Alfaar, A. S. (2015). Bilateral clear cell sarcoma of the kidney. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(2), 97–100. https://doi.org/10.1016/j.jnci.2015.03.002&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2015). Childhood Ewing Sarcoma of the Orbit. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;37&#039;&#039;(6), 433–437. https://doi.org/10.1097/MPH.0000000000000346&lt;br /&gt;
&lt;br /&gt;
Hassan, W. M., Mehanna, M., Nour, R., Yehia, D., Atta, N., &amp;amp; Alfaar, A. S. (2015). Association between quality of clinical trials and human development index in heart failure using JADAD scale. &#039;&#039;Principles and Practice of Clinical Research&#039;&#039;, &#039;&#039;1&#039;&#039;(2), 40–46. https://journal.ppcr.org/index.php/ppcrjournal/article/view/9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El-Nadi, E., Elzomor, H., Labib, R. M., Alfaar, A. S., Zaghloul, M. S., Taha, H., &amp;amp; Elwakeel, M. (2015). Childhood orbital rhabdomyosarcoma: Report from Children’s Cancer Hospital-57357-Egypt. &#039;&#039;Journal of Solid Tumors&#039;&#039;, &#039;&#039;2&#039;&#039;(5), 94. https://www.sciedupress.com/journal/index.php/jst/article/view/6603&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Alieldin, A., Taha, H., Montasr, M. M., Moussa, E., el Nadi, E., Ezzat, S., &amp;amp; Alfaar, A. S. (2015). Clinical presentation of intraocular retinoblastoma; 5-year hospital-based registry in Egypt. &#039;&#039;Journal of the Egyptian National Cancer Institute&#039;&#039;, &#039;&#039;27&#039;&#039;(4), 195–203. https://doi.org/10.1016/j.jnci.2015.09.002&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Zamzam, M., Abdalla, B., Magdi, R., &amp;amp; El-Kinaai, N. (2016). Childhood Ewing Sarcoma of Orbit: Is it So Fatal? &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;38&#039;&#039;(6), 493. https://doi.org/10.1097/MPH.0000000000000600&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Labib, R. M., Mostafa, M. M., Alfaar, A. S., Yehia, D., Alaa, M., Elzayat, M. G., Adel, M., Ezzat, S., &amp;amp; Abo El-Naga, S. (2016). Biorepository for Pediatric Cancer with Minimal Resources: Meeting the Challenges. &#039;&#039;Biopreservation and Biobanking&#039;&#039;, &#039;&#039;14&#039;&#039;(1), 9–16. https://doi.org/10.1089/bio.2015.0004&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Ezzat, S. (2017). Clinical Research Recession: Training Needs Perception Among Medical Students. &#039;&#039;Journal of Cancer Education : The Official Journal of the American Association for Cancer Education&#039;&#039;, &#039;&#039;32&#039;&#039;(4), 728–733. https://doi.org/10.1007/s13187-016-0995-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Nour, R., Bakry, M. S., Kamal, M., Hassanain, O., Labib, R. M., Rashed, W. M., Elzomor, H., Alieldin, A., Taha, H., Zaghloul, M. S., Ezzat, S., &amp;amp; AboElnaga, S. (2017). A change roadmap towards research paradigm in low-resource countries: retinoblastoma model in Egypt. &#039;&#039;International Ophthalmology&#039;&#039;, &#039;&#039;37&#039;&#039;(1), 111–118. https://doi.org/10.1007/s10792-016-0233-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Elzomor, H., Taha, H., Nour, R., Aleieldin, A., Zaghloul, M. S., Qaddoumi, I., &amp;amp; Alfaar, A. S. (2017). A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. &#039;&#039;Ophthalmic Genetics&#039;&#039;, &#039;&#039;38&#039;&#039;(4), 345–351. https://doi.org/10.1080/13816810.2016.1227995&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Hassan, W. M., Bakry, M. S., &amp;amp; Qaddoumi, I. (2017). Neonates with cancer and causes of death; lessons from 615 cases in the SEER databases. &#039;&#039;Cancer Medicine&#039;&#039;, &#039;&#039;6&#039;&#039;(7), 1817–1826. https://doi.org/10.1002/cam4.1122&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Zekri, W., Awad, M., Taha, H., Abdalla, B., &amp;amp; Alfaar, A. S. (2017). Nonfunctioning Adrenocortical Carcinoma in Pediatric Acute Lymphoblastic Leukemia: A Case Report of a Rare Multiple Primaries Combination. &#039;&#039;Journal of Pediatric Hematology/Oncology&#039;&#039;, &#039;&#039;39&#039;&#039;(2), 150–152. https://doi.org/10.1097/MPH.0000000000000699 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adly, M. H., Sobhy, M., Rezk, M. A., Ishak, M., Afifi, M. A., Shafie, A. el, Ali, M. A., Zekri, W., Alfaar, A. S., &amp;amp; Rashed, W. M. (2018). Risk of second malignancies among survivors of pediatric thyroid cancer. &#039;&#039;International Journal of Clinical Oncology&#039;&#039;, &#039;&#039;23&#039;&#039;(4), 625–633. https://doi.org/10.1007/s10147-018-1256-9&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Rashed, W. M., Saad, A. M., Al-Husseini, M. J., Galal, A. M., Ismael, A. M., Al-Tayep, A. M., el Shafie, A., Ali, M. A., &amp;amp; Alfaar, A. S. (2018). Incidence of adrenal gland tumor as a second primary malignancy: SEER-based study. &#039;&#039;Endocrine Connections&#039;&#039;, &#039;&#039;7&#039;&#039;(10), 1040–1048. https://doi.org/10.1530/EC-18-0304&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Al-Husseini, M. J., Saad, A. M., El-Shewy, K. M., Nissan, N. E., Gad, M. M., Alzuabi, M. A., &amp;amp; Samir Alfaar, A. (2018). Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study. &#039;&#039;International Journal of Neuroscience&#039;&#039;, &#039;&#039;0&#039;&#039;(0), 1–8. https://doi.org/10.1080/00207454.2018.1538989&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Chamdine, O., Elhawary, G. A. S., Alfaar, A. S., &amp;amp; Qaddoumi, I. (2018). The incidence of brainstem primitive neuroectodermal tumors of childhood based on SEER data. &#039;&#039;Child’s Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery&#039;&#039;, &#039;&#039;34&#039;&#039;(3), 431–439. https://doi.org/10.1007/s00381-017-3687-4&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Gad, M. M., Al-Husseini, M. J., AlKhayat, M. A., Rachid, A., Alfaar, A. S., &amp;amp; Hamoda, H. M. (2019). Suicidal death within a year of a cancer diagnosis: A population-based study. &#039;&#039;Cancer&#039;&#039;, &#039;&#039;125&#039;&#039;(6), 972–979. https://doi.org/10.1002/cncr.31876&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Reichhart, N., Schöberl, S., Keckeis, S., Alfaar, A. S., Roubeix, C., Cordes, M., Crespo-Garcia, S., Haeckel, A., Kociok, N., Föckler, R., Fels, G., Mataruga, A., Rauh, R., Milenkovic, V. M., Zühlke, K., Klussmann, E., Schellenberger, E., &amp;amp; Strauß, O. (2019). Anoctamin-4 is a bona fide Ca2+-dependent non-selective cation channel. &#039;&#039;Scientific Reports&#039;&#039;, &#039;&#039;9&#039;&#039;(1), 2257. https://doi.org/10.1038/s41598-018-37287-y&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Cordes, M., Bucichowski, P., Alfaar, A. S., Tsang, S. H., Almedawar, S., Reichhart, N., &amp;amp; Strauß, O. (2020). Inhibition of Ca2+ channel surface expression by mutant bestrophin-1 in RPE cells. &#039;&#039;FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology&#039;&#039;, &#039;&#039;May 2019&#039;&#039;, fj.201901202RR. https://doi.org/10.1096/fj.201901202RR&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Zekri, W., Hammad, M., Rashed, W. M., Ahmed, G., Elshafie, M., Adly, M. H., Elborai, Y., Abdalla, B., Taha, H., Elkinaae, N., Refaat, A., Younes, A., Alfaar, A. S., Younis, A., &amp;amp; Alfaar, A. S. (2020). The outcome of childhood adrenocortical carcinoma in Egypt: A model from developing countries. &#039;&#039;Pediatric Hematology and Oncology&#039;&#039;, 1–13. https://doi.org/10.1080/08880018.2019.1710309&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Saad, A. M., Elmatboly, A. M., Gad, M. M., Al-Husseini, M. J., Jazieh, K. A., Alzuabi, M. A., &amp;amp; Alfaar, A. S. (2020). Association of Brain Cancer With Risk of Suicide. &#039;&#039;JAMA Network Open&#039;&#039;, &#039;&#039;3&#039;&#039;(5), e203862. https://doi.org/10.1001/jamanetworkopen.2020.3862&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
El Zomor, H., Nour, R., Saad, A., Taha, H., Shelil, A. E., Aleieldin, A., Saad Zaghloul, M., &amp;amp; Alfaar, A. S. (2020). Unilateral retinoblastoma; natural history and an age-based protocol in 248 patients. &#039;&#039;Eye&#039;&#039;. https://doi.org/10.1038/s41433-020-01275-2&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Elzouki, S., Abdel-Rahman, M. H., Strauss, O., &amp;amp; Rehak, M. (2020). Uveal melanoma-associated cancers revisited. &#039;&#039;ESMO Open&#039;&#039;, &#039;&#039;5&#039;&#039;(6), e000990. https://doi.org/10.1136/esmoopen-2020-000990&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A. M., KhalafAllah, M. T., Elsherif, O. E., Osman, M. H., &amp;amp; Strauß, O. (2020). Second primary malignancies of eye and ocular adnexa after a first primary elsewhere in the body. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology&#039;&#039;. https://doi.org/10.1007/s00417-020-04896-1&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Bourne, R., Steinmetz, J. D., Flaxman, S., Briant, P. S., Taylor, H. R., Resnikoff, S., Casson, R. J., Abdoli, A., Abu-Gharbieh, E., Afshin, A., Ahmadieh, H., Akalu, Y., Alamneh, A. A., Alemayehu, W., Alfaar, A. S., Alipour, V., Anbesu, E. W., Androudi, S., Arabloo, J., … Vos, T. (2020). Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;, 1–14. https://doi.org/10.1016/S2214-109X(20)30425-3&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Adelson, J. D., Bourne, R. R. A., Briant, P. S., Flaxman, S. R., Taylor, H. R. B., Jonas, J. B., Abdoli, A. A., Abrha, W. A., Abualhasan, A., Abu-Gharbieh, E. G., Adal, T. G., Afshin, A., Ahmadieh, H., Alemayehu, W., Alemzadeh, S. A. S., Alfaar, A. S., Alipour, V., Androudi, S., Arabloo, J., … Vos, T. (2020). Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study. &#039;&#039;The Lancet Global Health&#039;&#039;, &#039;&#039;20&#039;&#039;. https://doi.org/10.1016/S2214-109X(20)30489-7&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
Hammad, M., Hosny, M., Khalil, E., Alfaar, A., &amp;amp; Fawzy, M. (2020). Pediatric ependymoma: A single-center experience from a developing country. &#039;&#039;Indian Journal of Cancer&#039;&#039;, &#039;&#039;55&#039;&#039;(1), 382–389. https://doi.org/10.4103/ijc.IJC_373_19&lt;br /&gt;
&lt;br /&gt;
Alfaar, A. S., Saad, A., Wiedemann, P., &amp;amp; Rehak, M. (2021). The epidemiology of uveal melanoma in Germany: a nationwide report of incidence and survival between 2009 and 2015. &#039;&#039;Graefe’s Archive for Clinical and Experimental Ophthalmology = Albrecht von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie&#039;&#039;, &#039;&#039;Accepted&#039;&#039;. https://doi.org/10.1007/s00417-021-05317-7&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=33</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=33"/>
		<updated>2021-10-10T15:13:43Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;==== Age-standardized Incidence rates ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?publish=yes Incidence rates per State]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRate-Ratiosperstate/UMRateRatios?publish=yes Incidence rate-ratios per state in comparison to the national incidence in US]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRateperagegroup/IncidenceperAgeGgroupsexFig?pub Incidence rates per age group]&lt;br /&gt;
&lt;br /&gt;
==== Trends: ====&lt;br /&gt;
&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforsexraceorigin/UMTrendsSex-Race-Origin?publish=yes Trend for sex, race and origin]&lt;br /&gt;
* [https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceTrendsforStageDiag_Confirmation/UMTrendsStage-Diag?publish=yes Trend for stage, and method of diagnostic confirmation]&lt;br /&gt;
&lt;br /&gt;
 &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=32</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=32"/>
		<updated>2021-10-10T15:02:30Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
Incidence rates&lt;br /&gt;
&lt;br /&gt;
Incidence rates per State&lt;br /&gt;
&lt;br /&gt;
Incidence rate-ration per state in comparison to the national incidence in US&lt;br /&gt;
&lt;br /&gt;
Trends:&lt;br /&gt;
&lt;br /&gt;
Trend for sex, race and origin&lt;br /&gt;
&lt;br /&gt;
Trend for stage, and method of diagnostic confirmation &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=31</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=31"/>
		<updated>2021-10-10T14:49:49Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;100%&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=30</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=30"/>
		<updated>2021-10-10T14:47:52Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: &lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&amp;lt;iframe key=&amp;quot;tableau&amp;quot; path=&amp;quot;UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; width=&amp;quot;800&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=29</id>
		<title>Uveal Melanoma in USA</title>
		<link rel="alternate" type="text/html" href="https://research.alfaar.de/index.php?title=Uveal_Melanoma_in_USA&amp;diff=29"/>
		<updated>2021-10-10T14:16:10Z</updated>

		<summary type="html">&lt;p&gt;WikiSysop: Replaced content with &amp;quot; &amp;lt;iframe src=&amp;quot;https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot;  width=&amp;quot;800&amp;quot; height=&amp;quot;6...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&lt;br /&gt;
&amp;lt;iframe src=&amp;quot;https://public.tableau.com/app/profile/ahmed.alfaar/viz/UMIncidenceRatesperstate/UMIncidenceRates?:embed=yes&amp;amp;:toolbar=no&amp;amp;:publish=yes&amp;quot; &lt;br /&gt;
width=&amp;quot;800&amp;quot; height=&amp;quot;600&amp;quot;&amp;gt;&amp;lt;/iframe&amp;gt;&lt;/div&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
</feed>